
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251EB78AEF4193051EB700438EC9A2.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="discon">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373629/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Discover Oncology">
<meta name="citation_title" content="The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years">
<meta name="citation_author" content="Shuman Kuang">
<meta name="citation_author_institution" content="Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563000 Guizhou China">
<meta name="citation_author_institution" content="Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China">
<meta name="citation_author" content="Mingjian Piao">
<meta name="citation_author_institution" content="Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China">
<meta name="citation_author" content="Chengjie Li">
<meta name="citation_author_institution" content="Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China">
<meta name="citation_author" content="Nan Zhang">
<meta name="citation_author_institution" content="Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China">
<meta name="citation_author" content="Jiongyuan Li">
<meta name="citation_author_institution" content="Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China">
<meta name="citation_author" content="Shuofeng Li">
<meta name="citation_author_institution" content="Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China">
<meta name="citation_author" content="Binhe Tian">
<meta name="citation_author_institution" content="Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifiyuan, Beijing, 100730 China">
<meta name="citation_author" content="Lijin Zhao">
<meta name="citation_author_institution" content="Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563000 Guizhou China">
<meta name="citation_author" content="Haitao Zhao">
<meta name="citation_author_institution" content="Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="16">
<meta name="citation_firstpage" content="1597">
<meta name="citation_doi" content="10.1007/s12672-025-03458-3">
<meta name="citation_pmid" content="40846795">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373629/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373629/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373629/pdf/12672_2025_Article_3458.pdf">
<meta name="description" content="Immunotherapy, remarkably immune checkpoint inhibitors, has shown significant efficacy and survival benefits in patients with various solid tumors. Although T lymphocytes have been extensively studied as the primary target cells, the role and ...">
<meta name="og:title" content="The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Immunotherapy, remarkably immune checkpoint inhibitors, has shown significant efficacy and survival benefits in patients with various solid tumors. Although T lymphocytes have been extensively studied as the primary target cells, the role and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373629/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12373629">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s12672-025-03458-3"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12672_2025_Article_3458.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373629%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12373629/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12373629/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373629/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-discon.png" alt="Discover Oncology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Discover Oncology" title="Link to Discover Oncology" shape="default" href="https://doi.org/10.1007/s12672-025-03458-3" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Discov Oncol</button></div>. 2025 Aug 22;16:1597. doi: <a href="https://doi.org/10.1007/s12672-025-03458-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s12672-025-03458-3</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Discov%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Discov%20Oncol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Discov%20Oncol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Discov%20Oncol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The landscape of research on B cell and immunotherapy in solid tumors over the past 20 years</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kuang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Shuman Kuang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Shuman Kuang</span></h3>
<div class="p">
<sup>1</sup>Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563000 Guizhou China </div>
<div class="p">
<sup>2</sup>Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kuang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuman Kuang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Piao%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mingjian Piao</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mingjian Piao</span></h3>
<div class="p">
<sup>2</sup>Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Piao%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mingjian Piao</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Chengjie Li</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Chengjie Li</span></h3>
<div class="p">
<sup>2</sup>Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chengjie Li</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Nan Zhang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Nan Zhang</span></h3>
<div class="p">
<sup>2</sup>Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nan Zhang</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jiongyuan Li</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jiongyuan Li</span></h3>
<div class="p">
<sup>2</sup>Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiongyuan Li</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Shuofeng Li</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Shuofeng Li</span></h3>
<div class="p">
<sup>2</sup>Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuofeng Li</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Binhe Tian</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Binhe Tian</span></h3>
<div class="p">
<sup>3</sup>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifiyuan, Beijing, 100730 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tian%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Binhe Tian</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Lijin Zhao</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Lijin Zhao</span></h3>
<div class="p">
<sup>1</sup>Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563000 Guizhou China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lijin Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Haitao Zhao</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Haitao Zhao</span></h3>
<div class="p">
<sup>2</sup>Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haitao Zhao</span></a>
</div>
</div>
<sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, 563000 Guizhou China </div>
<div id="Aff2">
<sup>2</sup>Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifuyuan, Wangfujing, 100730 Beijing China </div>
<div id="Aff3">
<sup>3</sup>Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, No.1 Shuaifiyuan, Beijing, 100730 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 7; Accepted 2025 Aug 19; Collection date 2025 Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12373629  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40846795/" class="usa-link">40846795</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Immunotherapy, remarkably immune checkpoint inhibitors, has shown significant efficacy and survival benefits in patients with various solid tumors. Although T lymphocytes have been extensively studied as the primary target cells, the role and application of B cells in solid tumor immunotherapy remain less understood. </p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">In this study, we conducted a bibliometric analysis of articles on solid tumor immunotherapy related to B cells, published from 2003 to March 28, 2024, in the Web of Science Core Collection. Co-authorship and keyword co-occurrence analyses were performed using VOSviewer, while CiteSpace was used to identify burst keywords and references.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">A total of 1995 publications were analyzed, revealing a year-on-year increase in articles. The most common keywords are “immunotherapy” and “expression”. The most frequently referenced publications focused on tertiary lymphoid structures and B-cell markers. The United States and China are the largest contributors to this field, with Frontiers in Immunology being the most prolific journal. This study provides a comprehensive overview of over 20 years of B cell and immunotherapy research in solid tumors, identifying key countries, institutions, authors, journals, and publications.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">The findings offer valuable insights into the relationship between B cells and immunotherapy in solid tumors. This study primarily unveils the current research hotspots concerning the role of B cells in immunotherapy, encompassing both fundamental research and clinical trials, as well as the accelerating emergence of an increasing number of B-cell-centric immunotherapies.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1007/s12672-025-03458-3.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Bibliometrics, CiteSpace, B cells, Immunotherapy, VOSviewer, Solid tumor</p></section></section><hr class="headless">
<p id="Par5">
<strong>Strength:</strong>
</p>
<ol class="list" style="list-style-type:decimal">
<li><p id="Par7">Utilized multiple complementary bibliometric tools (VOSviewer, CiteSpace, and R’s Bibliometrix) to enhance the robustness and multidimensionality of data analysis.</p></li>
<li><p id="Par8">Implemented a rigorous, independent dual-reviewer screening process with third-party arbitration to minimize selection bias during data extraction.</p></li>
<li><p id="Par9">Analyzed a 20-year longitudinal dataset (2003–2024) from the Web of Science Core Collection, capturing evolving trends in the field.</p></li>
</ol>
<p id="Par10">
<strong>Limitation:</strong>
</p>
<ol class="list" style="list-style-type:decimal">
<li><p id="Par12">Restricted data sources to English-language articles in the Web of Science, potentially excluding relevant non-English studies or gray literature.</p></li>
<li><p id="Par13">Excluded reviews and conference abstracts, which may overlook emerging hypotheses or unpublished findings critical to understanding the field’s trajectory.</p></li>
</ol>
<section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par14">The advent of immunotherapies has heralded a transformative era in cancer treatment, particularly for patients with metastatic cancers previously deemed incurable [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Treatments ranging from immune-checkpoint blockade therapy to adoptive cellular therapy have demonstrated sustained clinical responses across various cancer types, significantly altering the landscape of oncology [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Despite these advancements, the response rates to immunotherapy remain limited, and the underlying mechanisms are not fully understood, necessitating further investigation into the tumor-immune microenvironment (TIME) and its complex interplay with therapeutic interventions [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>].</p>
<p id="Par15">Immunotherapy remodels the TIME by directly altering immune cell functions and enhancing their anti-tumor effects [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. The TIME is highly intricate, encompassing diverse cells, including T cells, B cells, macrophages, dendritic cells, and other stromal components. In recent years, significant progress has been made in understanding how these components interact and contribute to the therapeutic outcomes of immunotherapy [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Notably, while the reinvigoration of effector T lymphocytes through immune checkpoint inhibitors (ICIs) has been a focal point, emerging evidence suggests that B cells may play a pivotal role in mediating the efficacy of these treatments [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p>
<p id="Par16">Tumor-infiltrating B cells (TIBs), with the ability to produce antibodies [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>], secrete cytokines [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>], and interact with other immune cells [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>], are reported to have a powerful prognostic value in various cancer types [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Recently, a review showed that the prognosis of 26 cancer types in the cancer genome atlas was positively associated with the proportion of TIBs [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. In some studies, TIBs have been associated with poor prognosis [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. This is mainly because of the difficulty distinguishing effector B cells from regulatory B cells. Indeed, within the tumor microenvironment, TIBs display considerable functional heterogeneity, broadly spanning naïve B cells, memory B cells, germinal center B cells, and antibody-secreting cells [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. After response to inflammatory factors, B cells could differentiate into regulatory B cells (Bregs), which, like regulatory T cells, served as an immunosuppressive factor [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. By secreting cytokines such as IL-10 and IL-35 and transforming growth factor beta or releasing metabolites such as gamma-aminobutyric acid, Bregs can suppress pro-inflammatory cells via programmed cell death 1 (PD-1)/ programmed cell death-ligand 1 (PD-L1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) pathways [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>–<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Except Bregs; multiple studies have found double-negative B cells, or atypical memory (AtM) B cells in aging mice, autoimmune diseases, and chronic infection models characterized by IgD<sup>−</sup>CD21<sup>−</sup> [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Similarly to T cell exhaustion, tumor AtM B cells exhibited an exhausted phenotype. These cells could expand in non-small cell lung cancer (NSCLC) and inversely correlate with affinity-matured B cell populations, leading to a worse prognosis [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p>
<p id="Par17">When it comes to structures associated with TIB responses, tertiary lymphoid structures (TLSs) are found to play an essential role in B cell differentiation, class switch, and somatic hypermutation [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>], which are associated with improved survival in several cancers [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>–<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. As for the relationship between immunotherapy and TLSs, a study has shown that TLSs and B cell signatures, rather than T cell signatures, are predictive of therapeutic responses to ICIs such as pembrolizumab and ipilimumab [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Moreover, the density of B cells and TLSs has been found to increase during treatment in patients who respond to immunotherapy, but not in non-responding patients [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. In the study of soft tissue sarcomas, the patients’ group featuring the presence of tumor-infiltrating lymphocytes (TILs) exhibited a significant response to pembrolizumab treatment, with 50% of patients showing favorable therapeutic outcomes. In stark contrast, patients belonging to the immunologically deserted group did not demonstrate any response to the same treatment [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. These correlations between B cell activity and therapeutic success point to a potential role of B cells in modulating the TIME to favor immunotherapy responses. Research related to B lymphocytes and immunotherapy has gradually become a hot topic.</p>
<p id="Par18">Bibliometrics is a field of study that uses quantitative and statistical methods to analyze the production and dissemination of research literature [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. It involves collecting, organizing, and analyzing bibliographic data, such as the number of citations, co-authorship patterns, and publication venues [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Bibliometrics has several advantages, including the ability to identify and quantify the impact of research, provide evidence-based assessments of scientific productivity, and track the dissemination and influence of study over time. Bibliometrics can also support the identification of research trends, emerging fields, and collaborations and inform strategic planning and resource allocation in research organizations [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. Bao et al. recently conducted a bibliometric analysis of tertiary lymphoid structures (TLS), revealing that recent studies have primarily focused on TLS-related cancer mechanisms, including immunotherapy, tumor microenvironment, tumor-infiltrating lymphocytes, prognosis, and immune checkpoint inhibition. As a key component of TLS, B cells play a critical role in tumor immunity and immunotherapy; however, bibliometric analyses specifically targeting B cells remain limited. Given their significance, a dedicated bibliometric study on B cells is warranted. With the growing volume of scientific literature and the increasing importance of research impact, bibliometrics will continue to play a significant role in evaluating and assessing research.</p>
<p id="Par19">This research has uncovered compelling evidence that B cells played an important role in solid tumor immunotherapies. Several studies have demonstrated that B cells could predict and affect the effectiveness of immunotherapies. However, the existing literature also highlights the need for further research to thoroughly understand the specific mechanisms or regulatory networks underlying the correlation between B cells and immunotherapies. This research aims to synthesize the present findings and trends in this field, providing a comprehensive overview of the current state of knowledge and understanding of the interplay between B cells and immunotherapies in solid tumors [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>].</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Data connection and screening</h3>
<p id="Par20">This study was designed as a cross-sectional study and was conducted on March 28, 2024, using the Web of Science Core Collection. Web of Science is widely regarded as the most influential scientific research database and one of the most frequently accessed academic databases, as it includes journals that are typically considered to have the highest quality [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. It is a widely employed database for conducting bibliometric analysis of scientific research in the healthcare realm. All relevant literature was retrieved and downloaded in “Plain text” format to avoid biases introduced by updates [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>].</p>
<p id="Par21">The retrieval and screening strategy for the literature is as follows: 1. The literature was limited using the TS (“topic,” including title, abstract, author’s keywords, and keywords Plus) keyword search strategy. The search strategy used was “immunotherapy” OR “immunotherapies” OR “immunotherapeutic” OR “immunotherapeutics” OR “ICI” OR “ICIs” OR “CPI” OR “immune-checkpoint inhibitor” OR “immune checkpoint inhibitor” OR “immune-checkpoint blockade” OR “immune checkpoint blockade” (Topic) and “Bursa Dependent Lymphocyte” OR “Bursa Dependent Lymphocytes” OR “Lymphocyte, Bursa-Dependent” OR “Lymphocytes, Bursa-Dependent” OR “B Lymphocyte” OR “B Lymphocytes” OR “Lymphocyte, B” OR “Lymphocytes, B” OR “B Cell” OR “B Cells” OR “Cell, B” OR “Cells, B” OR “B1 cell” OR “B2 cell” OR “B1 Cells” OR “B2 Cells” OR “plasma cell” OR “cell, plasma” OR “plasma cells” OR “cells, plasma” (Topic) and English (Language) and “neoplasm” OR “cancer” OR “neoplasia” OR “tumor” OR “malignancy” (Topic). The publication date range was set from January 1, 2003, to March 28, 2024. We initially excluded non-English literature as well as reviews and meetings. The screening of publications was conducted by three researchers specializing in relevant fields. The specific process was as follows: two researchers independently screened all the publications. If their opinions on a particular piece of publication were conflicting, the third researcher was consulted for the final evaluation. This ensured the exclusion of non-solid tumors and other irrelevant studies from the publications. The detailed process is illustrated in Fig. <a href="#Fig1" class="usa-link">1</a>.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373629_12672_2025_3458_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bcf/12373629/7ba024e31a73/12672_2025_3458_Fig1_HTML.jpg" loading="lazy" id="d33e428" height="1076" width="709" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flowchart of bibliometric analysis based on B lymphocytes and immunotherapy in solid tumor</p></figcaption></figure></section><section id="Sec4"><h3 class="pmc_sec_title">Data analysis and mapping</h3>
<p id="Par23">We performed bibliometric analysis using the software Citespace (version 6.1.R3) [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>], VOSviewer (version 1.6.18) [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>], Microsoft Office Excel 2021 and the Bibliometrix package (version 3.2.1) in R (4.0.3, <a href="https://www.r-project.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.r-project.org/</a>) [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. We utilized “Bibliometrix” to figure out basic bibliometric features and illustrate the collaboration between countries and authors. Running this R package after importing the target publications, we can also count the number of these publications in different countries, organizations, journals, etc. We used VOSviewer to analyze co-authorship among countries and institutions and to analyze keyword co-occurrences, which focuses on cluster analysis of scientific and technical papers at the aggregate level [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. After selecting the analysis type and analysis unit and removing duplicate words, VOSviewer will generate the co-occurrence network, time-overlapping co-occurrence analysis network, and heat map. CiteSpace is a citation analysis and visualization software. The software visualizes the structure and trends in the literature using “scientific knowledge mapping” [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. CiteSpace was employed to analyze citation bursts of keywords and cited references. Additionally, we used Microsoft Office Excel 2021 to build an exponential model fitting the cumulative publication numbers and frequency of keyword occurrence.</p>
<p id="Par24">No participant data was involved in the study, as all original data were sourced from publicly available databases, thus obviating the need for ethical review.</p></section></section><section id="Sec5"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec6"><h3 class="pmc_sec_title">Time distribution of publications</h3>
<p id="Par25">As shown in Fig. <a href="#Fig1" class="usa-link">1</a>, a total of 6549 relevant papers have been screened, and after excluding papers that did not adhere to the specified topic and article type requirements, a total of 1,995 papers were ultimately included in this study. Figure <a href="#Fig2" class="usa-link">2</a> displays a general upward trend in the number of publications focused on B lymphocytes and immunotherapy over the past two decades. This research area has become increasingly prominent, with 377 articles published in 2022, marking a 2217.65% increase from 17 articles in 2003. An exponential growth function was applied to analyze the publication trends over time, which reflected a similar pattern to actual growth (R<sup>2</sup> = 0.7731), indicating notable growth and expansion in the field of B cell and immunotherapy research.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373629_12672_2025_3458_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bcf/12373629/06caff6cc11a/12672_2025_3458_Fig2_HTML.jpg" loading="lazy" id="d33e478" height="759" width="709" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Clinical Events Timeline of B Cell-Based Immunotherapy</p></figcaption></figure><p id="Par27">The earliest publication in 2003 by Correa et al. investigated MUC1 mucin on B- and T-lymphocytes, identifying its role in T-cell and endothelial cell interactions and anti-tumor immunity [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. A noteworthy study conducted in 2005 revealed that, in tumor patients, gemcitabine treatment led to a significant reduction in myeloid suppressor cells in the spleens while preserving the population of B cells, suggesting gemcitabine could mitigate the immunosuppressive TIME and enhance the efficacy of cancer immunotherapy [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Another study reported in 2011 showed that B cell depletion could impair the function and proliferation of CD4(+) and CD8(+) T cells and thus enhance B16 melanoma growth in mice [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. In 2016, a study reported that memory B cells were associated with pathological complete response to neoadjuvant chemotherapy in estrogen receptor-negative breast tumors, illustrating the anti-tumor effect of B cells [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. In the early days before the emergence of ICIs, researchers focused much of their studies on B lymphocytes on cell number changes, protein-protein interactions, and cell-cell interactions in other antitumor therapies, and these roles served as theoretical support for the exploration of original therapeutic modalities such as chemotherapy plus immunotherapy.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Analysis of national publication counts</h3>
<p id="Par28">National publication analysis reveals the volume of articles published on B cells and immunotherapy across different countries and international collaboration among authors. A total of 63 countries and territories are represented in the study. Figure <a href="#Fig3" class="usa-link">3</a> shows that if we count the number of publications by country of corresponding author, China and the United States top the list with 828 and 484 articles, followed by Germany and Japan in that order. Comparing the trends in the number of articles published by different countries, both China and the United States are rapidly emerging in this field, and the number of Chinese authors involved in related research has gradually surpassed that of the United States in recent years. Sorting by country of all authors yields approximately the same results. Chinese authors lead the way with 3,091 publications, followed by the United States with 2537 publications, and Germany with 567 publications. Other notable contributors include France, Japan, and the UK, each with more than 250 publications. Figure <a href="#Fig4" class="usa-link">4</a> illustrates international collaborations, with the most frequent collaboration occurring between China and the United States (82 instances). Other significant collaborations involve the United States with Germany (29), the United States with Canada (27), and the United States with France (25). Figure <a href="#MOESM1" class="usa-link">S1</a> provides additional insights into countries/regions’ co-authorship analysis, including cluster and time-overlapping network analyses, which show similar results.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373629_12672_2025_3458_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bcf/12373629/7ec9766b9952/12672_2025_3458_Fig3_HTML.jpg" loading="lazy" id="d33e525" height="1169" width="685" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Top 10 countries with publications in the field of B-lymphocyte and immunotherapy. <strong>A</strong> Number of publications by country of corresponding author; <strong>B</strong> Changes in trends in the number of articles issued in different countries (<strong>C</strong>). Number of publications by country of full authorship</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373629_12672_2025_3458_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bcf/12373629/0c4105de49d3/12672_2025_3458_Fig4_HTML.jpg" loading="lazy" id="d33e535" height="355" width="709" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Global Collaborations in B cells and Immunotherapy and the Frequency of Collaboration Among Nations</p></figcaption></figure></section><section id="Sec8"><h3 class="pmc_sec_title">Analysis of institution publications</h3>
<p id="Par31">In our study on B lymphocytes and immunotherapy in solid tumors, we analyzed publications from 2,036 institutions worldwide. Figure <a href="#Fig5" class="usa-link">5</a> highlights the top 20 institutions by publication volume. The UTMD Anderson Cancer Center leads the list, with 193 publications, followed by the University of Texas System (191) and Harvard University (157). Sun Yat-sen University (140) and Fudan University (123) from China rank fourth and fifth, respectively. Most of these leading institutions are in the United States, with six originating from China. Apart from the United States and China, France is represented by Université Paris Cité, Unicancer and Institut National de la Santé et de la Recherche Médicale. The UK and Germany are represented by the University of London and the Helmholtz Association, respectively. Figure S2 presents an institutional co-authorship analysis, showcasing cluster and time-overlapping networks. U.S. institutions predominantly conducted early research, but in recent years, Chinese institutions like Sun Yat-sen University and Shanghai Jiaotong University have become increasingly active in this field.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373629_12672_2025_3458_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bcf/12373629/271390ceb2c6/12672_2025_3458_Fig5_HTML.jpg" loading="lazy" id="d33e552" height="273" width="709" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Top 20 institutions involved in research on B cells and Immunotherapy</p></figcaption></figure></section><section id="Sec9"><h3 class="pmc_sec_title">Analysis of publication quantity and journal impact</h3>
<p id="Par33">This study encompasses 1,995 articles published across 514 journals. Table <a href="#Tab1" class="usa-link">1</a> enumerates the top 10 journals by publication volume and their latest 2023 impact factors (IF) [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Among these, six journals are classified in the first quartile (Q1) of the Journal Citation Reports (JCR). The top journals include <em>Frontiers in Immunology</em> (<em>n</em> = 130, IF = 7.3, Q1), <em>Frontiers in Oncology</em> (<em>n</em> = 77, IF = 4.7, Q2), and <em>Journal for Immunotherapy of Cancer</em> (<em>n</em> = 73, IF = 10.9, Q1). This study also highlights the number of articles published in high-impact journals such as <em>Nature</em> (<em>n</em> = 8) and <em>Cell</em> (<em>n</em> = 5). The journal analysis demonstrates that publications in B-lymphocyte and solid tumor immunotherapy are mostly published in immunology and oncology-related journals, and there is no shortage of articles with great impact and major scientific and technological breakthroughs published in top-tier journals.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Top 10 journals in the field of B lymphocyte and immunotherapy</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Rank</th>
<th align="left" colspan="1" rowspan="1">Source</th>
<th align="left" colspan="1" rowspan="1">Articles</th>
<th align="left" colspan="1" rowspan="1">Country</th>
<th align="left" colspan="1" rowspan="1">IF</th>
<th align="left" colspan="1" rowspan="1">JCR-c</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">FRONTIERS IN IMMUNOLOGY</td>
<td align="center" colspan="1" rowspan="1">130</td>
<td align="left" colspan="1" rowspan="1">Switzerland</td>
<td align="center" colspan="1" rowspan="1">7.3</td>
<td align="left" colspan="1" rowspan="1">Q1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">FRONTIERS IN ONCOLOGY</td>
<td align="center" colspan="1" rowspan="1">77</td>
<td align="left" colspan="1" rowspan="1">Switzerland</td>
<td align="center" colspan="1" rowspan="1">4.7</td>
<td align="left" colspan="1" rowspan="1">Q2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">JOURNAL FOR IMMUNOTHERAPY OF CANCER</td>
<td align="center" colspan="1" rowspan="1">73</td>
<td align="left" colspan="1" rowspan="1">United Kingdom</td>
<td align="center" colspan="1" rowspan="1">10.9</td>
<td align="left" colspan="1" rowspan="1">Q1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">ONCOIMMUNOLOGY</td>
<td align="center" colspan="1" rowspan="1">67</td>
<td align="left" colspan="1" rowspan="1">United States</td>
<td align="center" colspan="1" rowspan="1">7.2</td>
<td align="left" colspan="1" rowspan="1">Q1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">CANCER IMMUNOLOGY IMMUNOTHERAPY</td>
<td align="center" colspan="1" rowspan="1">49</td>
<td align="left" colspan="1" rowspan="1">United States</td>
<td align="center" colspan="1" rowspan="1">5.8</td>
<td align="left" colspan="1" rowspan="1">Q1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">CANCERS</td>
<td align="center" colspan="1" rowspan="1">48</td>
<td align="left" colspan="1" rowspan="1">Switzerland</td>
<td align="center" colspan="1" rowspan="1">5.2</td>
<td align="left" colspan="1" rowspan="1">Q1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">CLINICAL CANCER RESEARCH</td>
<td align="center" colspan="1" rowspan="1">44</td>
<td align="left" colspan="1" rowspan="1">United States</td>
<td align="center" colspan="1" rowspan="1">11.5</td>
<td align="left" colspan="1" rowspan="1">Q1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">JOURNAL OF IMMUNOLOGY</td>
<td align="center" colspan="1" rowspan="1">36</td>
<td align="left" colspan="1" rowspan="1">United States</td>
<td align="center" colspan="1" rowspan="1">4.4</td>
<td align="left" colspan="1" rowspan="1">Q2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">FRONTIERS IN GENETICS</td>
<td align="center" colspan="1" rowspan="1">34</td>
<td align="left" colspan="1" rowspan="1">Switzerland</td>
<td align="center" colspan="1" rowspan="1">3.7</td>
<td align="left" colspan="1" rowspan="1">Q2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">SCIENTIFIC REPORTS</td>
<td align="center" colspan="1" rowspan="1">32</td>
<td align="left" colspan="1" rowspan="1">United Kingdom</td>
<td align="center" colspan="1" rowspan="1">4.6</td>
<td align="left" colspan="1" rowspan="1">Q2</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p42"><p>IF: impact factor; JCR: journal citation reports</p></div></div></section></section><section id="Sec10"><h3 class="pmc_sec_title">Research hotspot analysis</h3>
<section id="Sec11"><h4 class="pmc_sec_title">Most cited publications</h4>
<p id="Par35">We used R to identify the top twenty most cited papers, as shown in Table <a href="#Tab2" class="usa-link">2</a>. The most cited publication is “B cells and tertiary lymphoid structures promote immunotherapy response” by Beth A. Helmink, published in <em>Nature</em> in 2020 [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. It has been cited 1219 times, averaging 243.8 citations per year. The second and third most cited papers are “Tertiary lymphoid structures improve immunotherapy and survival in melanoma” (2020, <em>Nature</em>) and “B cells are associated with survival and immunotherapy response in sarcoma” with 1008 and 979 citations respectively. Both focus on the role of TLSs and B cells in tumor immunotherapy [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>].</p>
<section class="tw xbox font-sm" id="Tab2"><h5 class="obj_head">Table 2.</h5>
<div class="caption p"><p>Top 20 highly cited articles in the field of B cell and immunotherapy</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Rank</th>
<th align="left" colspan="1" rowspan="1">Paper</th>
<th align="left" colspan="1" rowspan="1">DOI</th>
<th align="left" colspan="1" rowspan="1">Total citations</th>
<th align="left" colspan="1" rowspan="1">Total citations per year</th>
<th align="left" colspan="1" rowspan="1">Normalized total citations</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">HELMINK BA, 2020, NATURE</td>
<td align="left" colspan="1" rowspan="1">
10.1038/s41586-019-1922-8
</td>
<td align="center" colspan="1" rowspan="1">1219</td>
<td align="center" colspan="1" rowspan="1">243.8</td>
<td align="center" colspan="1" rowspan="1">26.7665604</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">CABRITA R, 2020, NATURE</td>
<td align="left" colspan="1" rowspan="1">
10.1038/s41586-019-1914-8
</td>
<td align="center" colspan="1" rowspan="1">1008</td>
<td align="center" colspan="1" rowspan="1">201.6</td>
<td align="center" colspan="1" rowspan="1">22.1334642</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">PETITPREZ F, 2020, NATURE</td>
<td align="left" colspan="1" rowspan="1">
10.1038/s41586-019-1906-8
</td>
<td align="center" colspan="1" rowspan="1">979</td>
<td align="center" colspan="1" rowspan="1">195.8</td>
<td align="center" colspan="1" rowspan="1">21.4966879</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">VINCENT J, 2010, CANCER RES</td>
<td align="left" colspan="1" rowspan="1">
10.1158/0008-5472.CAN-09-3690
</td>
<td align="center" colspan="1" rowspan="1">899</td>
<td align="center" colspan="1" rowspan="1">59.9333333</td>
<td align="center" colspan="1" rowspan="1">9.47645819</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">SUZUKI E, 2005, CLIN CANCER RES</td>
<td align="left" colspan="1" rowspan="1">10.1158/1078 − 0432.CCR-05-0883</td>
<td align="center" colspan="1" rowspan="1">815</td>
<td align="center" colspan="1" rowspan="1">40.75</td>
<td align="center" colspan="1" rowspan="1">8.52906977</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">LINNEMANN C, 2015, NAT MED</td>
<td align="left" colspan="1" rowspan="1">
10.1038/nm.3773
</td>
<td align="center" colspan="1" rowspan="1">512</td>
<td align="center" colspan="1" rowspan="1">51.2</td>
<td align="center" colspan="1" rowspan="1">8.734571</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">7</td>
<td align="left" colspan="1" rowspan="1">ALI HR, 2016, PLOS MED</td>
<td align="left" colspan="1" rowspan="1">
10.1371/journal.pmed.1002194
</td>
<td align="center" colspan="1" rowspan="1">381</td>
<td align="center" colspan="1" rowspan="1">42.3333333</td>
<td align="center" colspan="1" rowspan="1">6.44002181</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">8</td>
<td align="left" colspan="1" rowspan="1">HERVAS-STUBBS S, 2011, CLIN CANCER RES</td>
<td align="left" colspan="1" rowspan="1">10.1158/1078 − 0432.CCR-10-1114</td>
<td align="center" colspan="1" rowspan="1">352</td>
<td align="center" colspan="1" rowspan="1">25.1428571</td>
<td align="center" colspan="1" rowspan="1">5.54520548</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">LINES JL, 2014, CANCER RES</td>
<td align="left" colspan="1" rowspan="1">
10.1158/0008-5472.CAN-13-1504
</td>
<td align="center" colspan="1" rowspan="1">336</td>
<td align="center" colspan="1" rowspan="1">30.5454545</td>
<td align="center" colspan="1" rowspan="1">7.06542056</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">10</td>
<td align="left" colspan="1" rowspan="1">THEMELI M, 2013, NAT BIOTECHNOL</td>
<td align="left" colspan="1" rowspan="1">
10.1038/nbt.2678
</td>
<td align="center" colspan="1" rowspan="1">307</td>
<td align="center" colspan="1" rowspan="1">25.5833333</td>
<td align="center" colspan="1" rowspan="1">6.58886653</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">KORTYLEWSKI M, 2009, NAT BIOTECHNOL</td>
<td align="left" colspan="1" rowspan="1">
10.1038/nbt.1564
</td>
<td align="center" colspan="1" rowspan="1">301</td>
<td align="center" colspan="1" rowspan="1">18.8125</td>
<td align="center" colspan="1" rowspan="1">5.94746988</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1">ZHOU GY, 2017, GASTROENTEROLOGY</td>
<td align="left" colspan="1" rowspan="1">
10.1053/j.gastro.2017.06.017
</td>
<td align="center" colspan="1" rowspan="1">293</td>
<td align="center" colspan="1" rowspan="1">36.625</td>
<td align="center" colspan="1" rowspan="1">7.12844365</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">13</td>
<td align="left" colspan="1" rowspan="1">MESSINA JL, 2012, SCI REP-UK</td>
<td align="left" colspan="1" rowspan="1">
10.1038/srep00765
</td>
<td align="center" colspan="1" rowspan="1">277</td>
<td align="center" colspan="1" rowspan="1">21.3076923</td>
<td align="center" colspan="1" rowspan="1">4.83894333</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">14</td>
<td align="left" colspan="1" rowspan="1">YUAN JD, 2008, P NATL ACAD SCI USA</td>
<td align="left" colspan="1" rowspan="1">
10.1073/pnas.0810114105
</td>
<td align="center" colspan="1" rowspan="1">269</td>
<td align="center" colspan="1" rowspan="1">15.8235294</td>
<td align="center" colspan="1" rowspan="1">6.88436019</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">HOLLERN DP, 2019, CELL</td>
<td align="left" colspan="1" rowspan="1">
10.1016/j.cell.2019.10.028
</td>
<td align="center" colspan="1" rowspan="1">260</td>
<td align="center" colspan="1" rowspan="1">43.3333333</td>
<td align="center" colspan="1" rowspan="1">6.31530705</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">16</td>
<td align="left" colspan="1" rowspan="1">DAS R, 2018, J CLIN INVEST</td>
<td align="left" colspan="1" rowspan="1">
10.1172/JCI96798
</td>
<td align="center" colspan="1" rowspan="1">254</td>
<td align="center" colspan="1" rowspan="1">36.2857143</td>
<td align="center" colspan="1" rowspan="1">5.72932331</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">17</td>
<td align="left" colspan="1" rowspan="1">DILILLO DJ, 2010, J IMMUNOL</td>
<td align="left" colspan="1" rowspan="1">
10.4049/jimmunol.0903009
</td>
<td align="center" colspan="1" rowspan="1">245</td>
<td align="center" colspan="1" rowspan="1">16.3333333</td>
<td align="center" colspan="1" rowspan="1">2.58257203</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">COPPOLA D, 2011, AM J PATHOL</td>
<td align="left" colspan="1" rowspan="1">
10.1016/j.ajpath.2011.03.007
</td>
<td align="center" colspan="1" rowspan="1">234</td>
<td align="center" colspan="1" rowspan="1">16.71428571</td>
<td align="center" colspan="1" rowspan="1">3.68630137</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">19</td>
<td align="left" colspan="1" rowspan="1">IKUTANI M, 2012, J IMMUNOL</td>
<td align="left" colspan="1" rowspan="1">
10.4049/jimmunol.1101270
</td>
<td align="center" colspan="1" rowspan="1">233</td>
<td align="center" colspan="1" rowspan="1">17.9230769</td>
<td align="center" colspan="1" rowspan="1">4.07030251</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">20</td>
<td align="left" colspan="1" rowspan="1">DURANTE MA, 2020, NAT COMMUN</td>
<td align="left" colspan="1" rowspan="1">
10.1038/s41467-019-14256-1
</td>
<td align="center" colspan="1" rowspan="1">227</td>
<td align="center" colspan="1" rowspan="1">45.4</td>
<td align="center" colspan="1" rowspan="1">4.984421</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec12"><h4 class="pmc_sec_title">Analysis of citation bursts</h4>
<p id="Par37">A citation burst indicates a significant increase in citations for a published article over a period of more than one year [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. We analyzed the top 25 emerging keywords and references from 2003 to 2024, as depicted in Figs. <a href="#Fig6" class="usa-link">6</a> and <a href="#Fig7" class="usa-link">7</a>. The blue line in the figure represents the time span of the analysis, while the red line indicates periods of notable content emergence. For keyword emergence, Fig. <a href="#Fig6" class="usa-link">6</a> enumerates the top 25 keywords. Terms such as “dendritic cells,” “monoclonal antibody,” “in vivo,” and “antigen” have demonstrated prolonged periods of prominence, highlighting these terms as key areas during the analyzed period. Figure <a href="#Fig7" class="usa-link">7</a> focuses on references, with the most prominent being a 2015 publication in <em>Nature Methods</em> titled “Robust enumeration of cell subsets from tissue expression profiles.”</p>
<figure class="fig xbox font-sm" id="Fig6"><h5 class="obj_head">Fig. 6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373629_12672_2025_3458_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bcf/12373629/385c5a7ac73d/12672_2025_3458_Fig6_HTML.jpg" loading="lazy" id="d33e1206" height="857" width="709" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Top 25 keywords with the strongest citation bursts on B cells and Immunotherapy</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig7"><h5 class="obj_head">Fig. 7.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373629_12672_2025_3458_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bcf/12373629/a60e05c74829/12672_2025_3458_Fig7_HTML.jpg" loading="lazy" id="d33e1216" height="443" width="709" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Top 25 references with the strongest citation bursts on B cells and Immunotherapy</p></figcaption></figure></section><section id="Sec13"><h4 class="pmc_sec_title">Frequency and clustering analysis of keywords</h4>
<p id="Par40">Among the 6,261 identified keywords, we consolidated those with similar meanings and applied a minimum occurrence threshold of 30 in VOSviewer. This resulted in 100 keywords meeting the criteria for analysis, which facilitated the creation of a keyword co-occurrence network, time-overlapping co-occurrence analysis network, and heatmap, as illustrated in Fig. <a href="#Fig8" class="usa-link">8</a>. Figure <a href="#Fig8" class="usa-link">8</a>A presents the cluster analysis, categorizing the 100 keywords into three distinct clusters. Red Cluster contains 39 keywords, including “B cell”, “T cell”, and “dendritic cells”. This cluster reflects basic research and experiments at the cellular level concerning B-cells and organismal immunity. And green Cluster contains 37 keywords, such as “cancer”, “expression”, “prognosis” and “biomarkers”. It indicates a transition towards specific tumor types and clinical investigations, exploring B-cells and immune-related biomarkers and prognosis. Blue Cluster contains 24 keywords, including “immunotherapy”, “chemotherapy”, “pembrolizumab”, “survival”, “tertiary lymphoid structures” and “non-small cell lung cancer”. This cluster focuses on real-world immunotherapy cohorts and clinical trials investigating B-cells and survival outcomes in various types of immunotherapies.</p>
<figure class="fig xbox font-sm" id="Fig8"><h5 class="obj_head">Fig. 8.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12373629_12672_2025_3458_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bcf/12373629/0ec87dbc24a1/12672_2025_3458_Fig8_HTML.jpg" loading="lazy" id="d33e1249" height="475" width="709" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Research hotspots on B cells and Immunotherapy. <strong>A</strong> Keyword co-occurrence network; <strong>B</strong> Time-overlapping co-occurrence analysis network of keywords; <strong>C</strong> Keyword co-occurrence heat map; <strong>D</strong> Wordcloud of keyword analysis</p></figcaption></figure><p id="Par42">Figure <a href="#Fig8" class="usa-link">8</a>B displays the temporal overlap visualization of the keywords. Keywords that emerged earlier are shown in purple, while more recent keywords are highlighted in yellow. This analysis suggests that from 2003 to 2024, research on B-cells and immunotherapy has transitioned from basic cellular studies to clinical applications. Recent research has increasingly focused on survival, prognosis, biomarkers, and other related components. Figure <a href="#Fig8" class="usa-link">8</a>C shows the heat map analysis of 100 keywords, where a higher frequency of occurrence is indicated by more yellow shading. The word cloud in Fig. <a href="#Fig8" class="usa-link">8</a>D visualizes keyword frequency, with larger words representing higher frequencies. Figure S3 also shows the trend of the top 10 keywords from 2003 to 2024. Figure S4 shows the changes in the main topics of interest and keywords from 2003 to 2024 in countries which have the highest number of articles. In addition, Figures S5 and S6 show the results of the authors’ co-authorship analysis and co-citation references analysis, respectively.</p>
<p id="Par43">In conclusion, we can see a clear evolution in the research landscape, highlighting B-cell and immunotherapy studies’ growing complexity and clinical relevance.</p></section></section></section><section id="Sec14"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par44">This review uses bibliometric analysis to synthesize the literature on the relationship and application of B lymphocytes in immunotherapy for solid tumors from 2003 to 2024. Combined with the trend changes in the number of publications in this field, the emergence of keywords, and highly cited references, it is obvious that the field pertaining to B cells and immunotherapy has undergone remarkable advancements in the era of ICIs.</p>
<p id="Par45">From 2003 to 2016, the annual number of publications remained below 50, with minor fluctuations. However, there was a rapid increase starting from 2016, peaking in 2022–2023. This trend coincides with the approval of ipilimumab in 2011 as the first anti-CTLA-4 monoclonal antibody for treating unresectable and metastatic melanoma, leading to the onset of ICIs therapy in oncology [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Similarly, Nivolumab, an anti-PD-1 monoclonal antibody, was approved for melanoma treatment in 2014, further spurring research and clinical trials involving PD-1 inhibitors [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. It’s shown that B cells could engage in immunotherapies by presenting antigens via T cell-dependent B cell receptors [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. The antigen-presenting function of B cells has long been studied, mainly investigating how they capture exogenous antigens and present them to T cells to activate the immune response via T-cell receptors. In 2015, Carsten et al. evaluated neoantigen-specific CD4 + T cell responses in melanoma patients by co-culturing autologous B cells and T cells. They detected CD4 + T cell responses against tumor-specific mutations by loading these mutations onto autologous B cells and co-culturing these modified B cells with patients’ CD4 + T cells [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. In 2017, Jill E. Slansky et al. demonstrated for the first time using fresh ex vivo tumor samples from NSCLC patients that TIBs can present antigens to CD4 + TILs and influence their activation or suppression phenotype. Moreover, TIBs themselves could exhibit a depletion phenotype, and their levels can be used as a marker for immunotherapy. Increasing the antigen presentation of TIBs to CD4 + TILs or reversing the depletion of the TIBs phenotype in the TIME could further enhance tumor-specific immune responses [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. Furthermore, depending on the expression of major histocompatibility complex -II and after activating CD40, B lymphocytes can trigger secondary T cell responses and further stimulate anti-tumor immunity by antigen presentation [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. The researchers also identified that a specific cell surface molecule named T cell immunoglobulin and mucin domain 1 is expressed on specific B lymphocyte subsets. Inhibition of its expression could enhance B cell activation and increase antigen presentation and co-stimulation, resulting in the expansion of tumor-specific effector T cells [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. These molecules affecting B cell functions may be a promising research direction that can be further explored.</p>
<p id="Par46">Publications from China and the United States dominate the top ten countries with the most publications, each exceeding 400. This underscores the significant contribution of Chinese and the United States institutions to high-output research. Notably, rising bibliometric trends—particularly the shift toward TLS and B-cell signatures as prognostic biomarkers—parallel emerging omics-driven advances. Single-cell transcriptomics and spatial proteomics now enable precise deconvolution of B-cell functional states within tumor microenvironments, while multi-omics integration elucidates context-dependent crosstalk between B cells and stromal components. Leveraging these technologies will be essential for translating descriptive bibliometric patterns into mechanistic insights that drive next-generation immunotherapies. Collaborations between countries are also noteworthy, particularly between China and the United States, followed by partnerships between the United States and Germany, Canada, and France.</p>
<p id="Par47">China, the United States, and Germany share a similar focus in this area, with a gradual shift from early in vitro and in vivo topics to large-scale clinical trials and antibody-based drugs that have been conducted in recent years. In recent years, “ipilimumb”, “favorable prognosis”, “open label”. “pembrolizumab”, ‘survival’ and other topics have become more and more frequent in Chinese and American studies, suggesting that research on the efficacy and prognosis of various new drugs is becoming a hot topic. The conversion path from basic to clinical is very clear. In a globalized, digitized, and informatized economy, international collaboration enhances the rigor and reliability of academic results. China, in particular, should strive for broader cooperation with institutions in other countries to benefit more from global collaboration.</p>
<p id="Par48">A comparative view highlights clear differences in research output between China (<em>n</em> = 828) and the United States (<em>n</em> = 484) in the field of B cells and immunotherapy. China’s substantial publication volume is largely attributable to sustained governmental investment and supportive national policies, which have facilitated the rapid expansion of research capacity. Moreover, an emphasis on enhancing academic visibility through high publication counts further drives output. In contrast, the United States benefits from a long-standing academic tradition, well-established research infrastructure, and extensive international collaborations, factors that collectively contribute to higher overall research quality and citation impact. Moving forward, China is expected to strengthen research innovation and deepen global partnerships, thereby enhancing its influence within the international scientific community.</p>
<p id="Par49">The China–US collaboration, noted for 82 instances, indeed reflects significant cross-border research engagement. To assess the equity and depth of these partnerships, co-first authorships serve as a valuable indicator. In our study, many instances of co-first authorships between Chinese and US researchers were identified, such as the collaborative empirical study on faculty and student perceptions of academic incivility in Chinese nursing education involving US and Chinese faculty [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>], and the conference report from the US Chinese Anti-Cancer Association (USCACA) meeting on genomics in personalized cancer medicine and its impact on early drug development in China [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>], demonstrating genuine collaborative effort and shared contribution to the research output. These examples underscore the equitable nature and depth of China–US collaborations in this field.</p>
<p id="Par50">JCR categorizes journals into four quartiles (Q1-Q4) based on IF, which served as strong indicators of the journal’s impact [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Frontiers in Immunology leads in publication volume (<em>n</em> = 130), driven in part by its open-access model, efficient review process (average 2-month cycle), and relatively low publication threshold. In contrast, Nature (IF = 50.5) published only eight articles, reflecting stringent selectivity and an emphasis on transformative research. Although Nature’s total citation count is lower due to its smaller output, its average citations per article are markedly higher (175.25 vs. 32.05 for Frontiers in Immunology), underscoring its exceptional per-article influence. Nature has fewer total citations but higher average citations per article; conversely, Frontiers in Immunology has a lower average citation per article but a larger total citation count. Conversely, Frontiers in Immunology, despite its lower per-article citation rate, achieves a higher cumulative citation count owing to its large publication volume. This divergence illustrates the quality–quantity spectrum: high-throughput journals facilitate rapid knowledge dissemination, whereas elite journals prioritize seminal impact. Among the top 10 journals, 60% are classified as Q1, with Clinical Cancer Research having the highest impact factor (IF = 10.4) in this group.</p>
<p id="Par51">The number of citations of a publication can serve as a valuable indicator of research hotspots and significant breakthroughs. Our analysis of the top ten publications highlights the field of TLSs. TLSs are ectopic lymphoid organs that form under non-physiological conditions in non-lymphoid tissues during chronic inflammation, including autoimmune diseases and tumors [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. In the TIME, TLSs promote immune cell infiltration into solid tumors, significantly correlating with survival in untreated patients [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. TLSs are sites where initial/memory B-cells transform into plasma cells, producing antibodies (mainly IgG and IgA) directly against tumors [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>]. The development of TLSs are associated with improved responses to ICIs, highlighting the importance of B cells in immunotherapy [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>].</p>
<p id="Par52">The most cited publication in our study is “B cells and tertiary lymphoid structures promote immunotherapy response” by Beth A Helmink, published in Nature in 2020. It has been cited 1219 times so far, with an average of 243.8 citations per year. In this pioneering article, the authors demonstrate the role of B cells and TLSs, which serves as markers for ICIs therapy. Also, B cell markers are found to be the most differentially expressed genes in responding versus non-responding tumors. Using RNA sequencing and single-cell sequencing, the authors found that immune responders had significantly more B-cell receptor diversity than non-responders. Moreover, tumor tissues from responders had significantly higher memory B-cell frequency, whereas a significantly higher frequency of B-cells was observed in non-responders. However, this study has two main limitations: the relatively small cohort sample size and the homogeneity of the treatment regimen, which may limit the generalizability and robustness of the findings [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p>
<p id="Par53">These highly cited publications mainly confirm the biomarker role of B-lymphocytes and TLSs and are one of the important future research directions explored in several cancer types in subsequent years [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. Similar to the article above, by use of single-cell transcriptome sequence and high-plex proteomic analysis, Cabrita et al. showed that TLSs formation and the coexistence of CD8 + T cells and CD20 + B cells in metastatic melanoma was correlated with longer survival, which was independent of other clinical variables [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. In another key publication, Petitprez et al. (2020) found that B cells could strongly predict the prognosis of soft tissue sarcoma, independent of T lymphocyte and cytotoxic component levels. The presence of TLSs was also beneficial for pembrolizumab immunotherapy treatment [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. The three aforementioned highly cited papers, released around the same time, all employed multi-omics analysis to demonstrate the promising potential of B-cells and tertiary lymphoid structures as markers for immunotherapy in different tumor types. Although the mechanisms were still not well understood at that time, they still proposed relevant ideas and future research directions, e.g., secretion of cytokines by B-cells for recruiting immune cells and differentiation of memory B-cells into plasma cells for antibody production. Indeed, TIL-B can produce in situ antibodies within tumor tissues, especially the tumor-specific IgG [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>, <a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. Also, the dynamic changes and the predictive values of B-lymphocytes after treatment with ICIs have been confirmed in different tumor types like NSCLC and intrahepatic cholangiocarcinoma [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>–<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>]. Although the specific immune response network is still poorly understood, the humoral antitumor immune response detected in TLSs and its characterization opens the way for developing new vaccines and antibody therapeutic strategies [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>].</p>
<p id="Par54">Tertiary lymphoid structures (TLS) serve as critical hubs for B cell activation and antigen presentation, significantly enhancing antitumor immunity and predicting favorable responses to immune checkpoint inhibitors. However, TLS formation is not universal across all tumor types; it exhibits substantial heterogeneity dependent on anatomical and immunosuppressive niche characteristics. For instance, glioblastoma’s immune-excluded niche—marked by the blood-brain barrier, immunosuppressive cytokines, and restricted T-cell infiltration—severely impedes TLS development. Similarly, pancreatic ductal adenocarcinoma, characterized by a dense desmoplastic stroma and an immunosuppressive microenvironment, also shows limited TLS formation. This tumor-specific variation necessitates caution when generalizing TLS as a pan-cancer biomarker, urging context-dependent evaluation of its clinical applicability.</p>
<p id="Par55">B cells may play a positive role in the TIME, such as the observation that B cell-depleting can result in the progression and metastasis of B16 melanoma. In this model, researchers proved that the INF-γ production role of the T helper type 1 cells was impaired after B cell depletion [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. What’s more, after treating with ICIs in the mouse breast model, both B cells and follicular helper T cells were activated. The researchers also illustrated that B cell activation of T cells and the generation of antibody are key to immunotherapy response and propose a new biomarker for immune checkpoint therapy [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. As for in vivo research, for soft tissue sarcoma patients treated with PD-1, B cells was considered as the strongest prognostic factor no matter in high or low CD8 + T cells contents [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. In melanoma, patients with higher levels of TLSs had better prognosis when treated by ICIs. Treatment responders had a significant higher level of the CXCR4 signaling, cytokine receptor interaction and chemokine signaling pathways than non-responders, which may improve the antigen expression ability of B cells to activate T cell functions [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p>
<p id="Par56">Regulatory B cells (Bregs) typically exert immunosuppressive functions via secreting IL-10 and TGF-β, contributing to tumor immune escape. Consequently, higher Breg infiltration correlates with poor prognosis in melanoma and gastric cancer. While regulatory B cells (Bregs) are frequently characterized by their immunosuppressive functions—mediated through cytokines like IL-10 and TGF-β—this dichotomous view oversimplifies their functional plasticity. Growing evidence highlights context-dependent Breg roles: in breast cancer models, PD-1/CTLA-4 blockade expanded IgG + plasma cells derived from Breg precursors, enhancing antitumor responses. Such plasticity, driven by dynamic microenvironmental cues (e.g., cytokine gradients, metabolic stress), necessitates reevaluating Bregs as adaptable immune modulators rather than uniformly suppressive entities. Additionally, in lung cancer immunotherapy, Bregs have been shown to reduce the occurrence of adverse immune-related reactions.</p>
<p id="Par57">On the other hand, numerous studies have demonstrated that B cells may play a pivotal role in promoting tumor progression and metastasis. By mediating antibody-induced inflammation, the complement system can exert protumorigenic effects in both CMT and TC1 lung cancer models [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>, <a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>]. In the studies of melanoma patients treated with ICIs, it was observed that non-responders exhibited significantly elevated levels of Bregs compared to responders. Additionally, a higher Breg cell score was found to be correlated with a shorter overall survival [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. In other kinds of tumors, the frequencies of Bregs correlated with shorter overall survival in bladder cancer and gastric cancer [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>, <a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>], and the coexistence of Bregs with Tregs correlates with shorter metastasis-free survival in breast cancer [<a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]. Bregs may exert their immunomodulatory effects by secreting cytokines, such as IL-10, IL-35, and TGF-beta, or by releasing metabolites like gamma-aminobutyric acid, thereby suppressing the activation and function of pro-inflammatory cells, encompassing monocytes, dendritic cells, T helper cells, and CD8 + T lymphocytes [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>–<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>].</p>
<p id="Par58">In recent years, with the development of single-cell sequencing, various subclusters of B-lymphocytes capable of affecting TIME have been gradually identified [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>]. In mouse models of breast cancer, PD-1/CTLA-4 antibody therapy resulted in the expansion of B cells, especially the IgG + plasma cells, leading to a favorable ICIs response [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. In human patients with breast cancer, TIL-B was divided into five clusters and unusual cell types, in which follicular B cells have a strong correlation with immunotherapy efficacy [<a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>]. In cutaneous melanoma, CD20 + TIBs were observed in patients responding to ICIs. These B cells enriched for genes such as FCRL5, IDO1, IFNG, and BTLA displayed a prognostic value [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. In renal carcinoma, potential predictive biomarkers expressed on B cells in ICIs responders were also identified [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. Intratumoral B-cell receptor diversity in TIME is also a biomarker for predicting response to immunotherapy [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]. The importance of TIBs as anti-tumor immune drivers and their potential role in regulating myeloid-derived suppressor cells is also known as one of the hotspots in recent years [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. As for the immunotherapy-related adverse events (irAEs), changes in some B-lymphocyte subsets have also been shown to correlate with the incidence rate of irAEs [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>–<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>]. Additionally, due to the heterogeneity of antigen expression in solid tumors and the challenges T cells face in infiltrating these tumors, CAR-T therapy remains in the exploratory stage for solid tumors [<a href="#CR82" class="usa-link" aria-describedby="CR82">82</a>]. Most CAR-T products are still in phase I clinical trials, and thus, there are fewer studies related to B lymphocytes [<a href="#CR83" class="usa-link" aria-describedby="CR83">83</a>, <a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>].</p>
<p id="Par59">As for keyword frequency analysis and word clouds, keywords like “immunotherapy”, “expression”, “cancer”, “b-cells”, “survival”, “t-cells”, “dendritic cells”, “lymphocytes” and “therapy” were identified, reflecting the main themes discussed.</p>
<p id="Par60">Citation burst analysis using CiteSpace highlighted significant changes in citations over time. Researchers can use keywords and cited references with burst features to explore hotspots of research. In this study, since 2018, keywords like “antitumor activity,” “inflammation,” and “melanoma” have become prominent. The keyword “multicenter” appearing in 2022 indicates the importance of large-scale clinical trials and multicenter cooperation. The reference with the highest burst strength was “Robust enumeration of cell subsets from tissue expression profiles,” introducing CIBERSORT, a method for identifying cell subsets from gene expression profiles. This method has been pivotal for analyzing B-cell-related markers and therapeutic targets [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>]. The result also highlights the reference of “xCell: digitally portraying the tissue cellular heterogeneity landscape”, which also provided a valuable method to enumerate cell subsets from transcriptomes [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>].</p>
<p id="Par61">While our study utilized well-established bibliometric tools such as VOSviewer and CiteSpace for network visualization and clustering analysis, it is important to acknowledge certain limitations inherent to these tools. For example, VOSviewer’s clustering algorithm may tend to group high-frequency keywords more prominently, potentially overlooking emerging but less frequent terms. Similarly, CiteSpace’s citation burst detection is sensitive to temporal parameters, which could influence the identification of research frontiers. Future studies may consider using complementary methods or sensitivity analyses to validate these results and enhance robustness.</p>
<p id="Par62">Previous studies have provided a comprehensive bibliometric perspective on cancer immunotherapy research, highlighting the dominant role of T-cell–based therapies in recent investigations [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>]. In contrast, our work focuses on the emerging and distinctive role of B cells, suggesting a more diversified landscape of immune-cell research in the future [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. Another study explored the tumor microenvironment, emphasizing the complex cell–cell interactions, which aligns closely with our findings that highlight the crucial interactions between B cells and other immune cells within the tumor milieu [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>]. Additionally, some research has pointed out the presence of database selection bias in bibliometric analyses, reminding us that reliance on specific databases may overlook non-indexed or non-English literature, indicating an area for future improvement [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>]. Furthermore, another study stressed the importance of integrating quantitative and qualitative analyses in bibliometric research on cancer drug discovery, inspiring us to consider incorporating qualitative evaluation methods in future studies of B-cell–related cancer immunotherapy to gain deeper insights [<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]. Lastly, the necessity of regular updates in bibliometric analyses due to the rapid progress in cancer research has been emphasized, a principle that is equally applicable to our focus on B cells in cancer immunotherapy, underscoring the need for continuous monitoring to capture emerging trends and developments. We sincerely appreciate the reviewer’s constructive feedback, which has undoubtedly improved the quality of our manuscript.</p>
<p id="Par63">Another limitation of this study is the data cutoff in March 2024, which may exclude some of the most recent publications; however, such a lag is common in bibliometric analyses due to the time required for indexing, analysis, and peer review.</p>
<p id="Par64">Furthermore, the exclusive use of citation-based tools like VOSviewer and CiteSpace may favor high-frequency terms and mainstream research, limiting the detection of emerging or niche topics. The exclusion of gray literature and non-English publications may further bias the results, underscoring the need for more inclusive data sources and analytical approaches in future studies.</p></section><section id="Sec15"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par65">In recent years, research on B lymphocytes and immunotherapy in relation to solid tumors has garnered increasing attention. The volume of publications has grown annually over the past 20 years, with a significant surge in the last three years. This study exhibits the countries and institutions leading global research in B lymphocyte and immunotherapy studies. Frontiers in Immunology emerges as the most active journal, while China and the United States are the most prolific countries in this field.</p>
<p id="Par66">B-lymphocytes, with the ability to produce antibodies, present antigens, secrete cytokines, and interact with other immune cells, can directly or indirectly activate the anti-tumor immunity in immunotherapies. Key research areas include the role of B lymphocytes and intratumoral TLSs in predicting and affecting immunotherapy efficacy and exploring related mechanisms. Another hot topic is the studies of B lymphocytes as target cells to enhance the efficacy of ICIs, which may be pivotal for future research. To sum up, this comprehensive overview of the evolution and frontiers of this field serves as a valuable resource for researchers and policymakers new to this domain [<a href="#CR90" class="usa-link" aria-describedby="CR90">90</a>].</p></section><section id="Sec16"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12373629/bin/12672_2025_3458_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 1.</a><sup> (4.4MB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors thank the Web of Science™ (WOS) team for using their data.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>TIME</dt>
<dd><p id="Par70">Tumor-immune microenvironment</p></dd>
<dt>TIBs</dt>
<dd><p id="Par71">Tumor-infiltrating B-lymphocytes</p></dd>
<dt>Bregs</dt>
<dd><p id="Par72">Regulatory B cells</p></dd>
<dt>Tregs</dt>
<dd><p id="Par73">Regulatory T cells</p></dd>
<dt>TILs</dt>
<dd><p id="Par74">Tumor-infiltrating lymphocytes</p></dd>
<dt>IF</dt>
<dd><p id="Par75">Impact factor</p></dd>
<dt>JCR</dt>
<dd><p id="Par76">Journal citation report</p></dd>
<dt>AtM</dt>
<dd><p id="Par77">Atypical memory</p></dd>
<dt>TLSs</dt>
<dd><p id="Par78">Tertiary lymphoid structures</p></dd>
<dt>ICIs</dt>
<dd><p id="Par79">Immune checkpoint inhibitors</p></dd>
<dt>PD-1</dt>
<dd><p id="Par80">Programmed cell death 1</p></dd>
<dt>PD-L1</dt>
<dd><p id="Par81">Programmed cell death-ligand 1</p></dd>
<dt>CTLA-4</dt>
<dd><p id="Par82">Cytotoxic T-lymphocyte associated protein 4</p></dd>
<dt>NSCLC</dt>
<dd><p id="Par83">Non-small cell lung cancer</p></dd>
<dt>irAEs</dt>
<dd><p id="Par84">Immunotherapy-related adverse events</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>The authors confirm their contribution to the paper as follows: Study conception and design: SK, MP, NZ, JL, CL. Data collection: SK, MP, CL. Analysis and interpretation of results: SK, MP, CL. Draft manuscript preparation: SK. References research and critical revision of the manuscript: ZX, SL, SW, BT, LZ. All authors reviewed the results and approved the final version of the manuscript. LZ、HZ acts as a guarantor of the study.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by Beijing Natural Science Foundation (L248022), National High Level Hospital Clinical Research Funding[2022-PUMCH-B-128], CAMS Innovation Fund for Medical Sciences (CIFMS) [2021-I2M-1-061] [2021-I2M-1-003], CSCO-hengrui Cancer Research Fund [Y-HR2019-0239][Y-HR2020MS-0415][Y-HR2020QN-0414], CSCO-MSD Cancer Research Fund [Y-MSDZD2021-0213]. Lijin Zhao is supported by the National Natural Science Foundation of China (NSFC) (No. 81960125) and the Department of Science and Technology of Guizhou Province (No. Qiankehe Foundation [2020] 1Y302).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>All data supporting the findings of this study are available within the paper. For more information, please contact the corresponding author.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par67">Not applicable.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par68">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par69">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Shuman Kuang, Mingjian Piao, Chengjie Li, Nan Zhang and Jiongyuan Li contributed equally to this work.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Lijin Zhao, Email: lijin.zhao@zmu.edu.cn.</p>
<p>Haitao Zhao, Email: zhaoht@pumch.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Oliveira G, Wu CJ. Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer. 2023;23:295–316.
</cite> [<a href="https://doi.org/10.1038/s41568-023-00560-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10773171/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37046001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oliveira%20G,%20Wu%20CJ.%20Dynamics%20and%20specificities%20of%20T%20cells%20in%20cancer%20immunotherapy.%20Nat%20Rev%20Cancer.%202023;23:295%E2%80%93316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17:807–21.
</cite> [<a href="https://doi.org/10.1038/s41423-020-0488-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7395159/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32612154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Zhang%20Z.%20The%20history%20and%20advances%20in%20cancer%20immunotherapy:%20Understanding%20the%20characteristics%20of%20tumor-infiltrating%20immune%20cells%20and%20their%20therapeutic%20implications.%20Cell%20Mol%20Immunol.%202020;17:807%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Wei SC, Duffy CR, Allison JP. Fundamental mechanisms of immune checkpoint Blockade therapy. Cancer Discov. 2018;8:1069–86.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-18-0367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30115704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20SC,%20Duffy%20CR,%20Allison%20JP.%20Fundamental%20mechanisms%20of%20immune%20checkpoint%20Blockade%20therapy.%20Cancer%20Discov.%202018;8:1069%E2%80%9386." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Galon J, Bruni D. Tumor immunology and tumor evolution: intertwined histories. Immunity. 2020;52:55–81.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2019.12.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31940273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Galon%20J,%20Bruni%20D.%20Tumor%20immunology%20and%20tumor%20evolution:%20intertwined%20histories.%20Immunity.%202020;52:55%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Littman DR. Releasing the brakes on cancer immunotherapy. Cell. 2015;162:1186–90.
</cite> [<a href="https://doi.org/10.1016/j.cell.2015.08.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26359975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Littman%20DR.%20Releasing%20the%20brakes%20on%20cancer%20immunotherapy.%20Cell.%202015;162:1186%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Fridman WH, Petitprez F, Meylan M, Chen TW-W, Sun C-M, Roumenina LT et al. B cells and cancer: to B or not to B? J Exp Med. 2021;218.</cite> [<a href="https://doi.org/10.1084/jem.20200851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7754675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33601413/" class="usa-link">PubMed</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Sharonov GV, Serebrovskaya EO, Yuzhakova DV, Britanova OV, Chudakov DM. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol. 2020;20:294–307.
</cite> [<a href="https://doi.org/10.1038/s41577-019-0257-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31988391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sharonov%20GV,%20Serebrovskaya%20EO,%20Yuzhakova%20DV,%20Britanova%20OV,%20Chudakov%20DM.%20B%20cells,%20plasma%20cells%20and%20antibody%20repertoires%20in%20the%20tumour%20microenvironment.%20Nat%20Rev%20Immunol.%202020;20:294%E2%80%93307." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Laumont CM, Banville AC, Gilardi M, Hollern DP, Nelson BH. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat Rev Cancer. 2022;22:414–30.
</cite> [<a href="https://doi.org/10.1038/s41568-022-00466-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9678336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35393541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Laumont%20CM,%20Banville%20AC,%20Gilardi%20M,%20Hollern%20DP,%20Nelson%20BH.%20Tumour-infiltrating%20B%20cells:%20immunological%20mechanisms,%20clinical%20impact%20and%20therapeutic%20opportunities.%20Nat%20Rev%20Cancer.%202022;22:414%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Yin W, Jiang X, Tan J, Xin Z, Zhou Q, Zhan C, et al. Development and validation of a tumor mutation Burden-Related immune prognostic model for Lower-Grade glioma. Front Oncol. 2020;10:1409.
</cite> [<a href="https://doi.org/10.3389/fonc.2020.01409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7468526/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32974146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yin%20W,%20Jiang%20X,%20Tan%20J,%20Xin%20Z,%20Zhou%20Q,%20Zhan%20C,%20et%20al.%20Development%20and%20validation%20of%20a%20tumor%20mutation%20Burden-Related%20immune%20prognostic%20model%20for%20Lower-Grade%20glioma.%20Front%20Oncol.%202020;10:1409." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Pan Q, Wang L, Chai S, Zhang H, Li B. The immune infiltration in clear cell renal cell carcinoma and their clinical implications: A study based on TCGA and GEO databases. J Cancer. 2020;11:3207–15.
</cite> [<a href="https://doi.org/10.7150/jca.37285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7097965/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32231726/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pan%20Q,%20Wang%20L,%20Chai%20S,%20Zhang%20H,%20Li%20B.%20The%20immune%20infiltration%20in%20clear%20cell%20renal%20cell%20carcinoma%20and%20their%20clinical%20implications:%20A%20study%20based%20on%20TCGA%20and%20GEO%20databases.%20J%20Cancer.%202020;11:3207%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Glass DR, Tsai AG, Oliveria JP, Hartmann FJ, Kimmey SC, Calderon AA, et al. An integrated Multi-omic Single-Cell atlas of human B cell identity. Immunity. 2020;53:217–e2325.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2020.06.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7369630/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32668225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Glass%20DR,%20Tsai%20AG,%20Oliveria%20JP,%20Hartmann%20FJ,%20Kimmey%20SC,%20Calderon%20AA,%20et%20al.%20An%20integrated%20Multi-omic%20Single-Cell%20atlas%20of%20human%20B%20cell%20identity.%20Immunity.%202020;53:217%E2%80%93e2325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Michaud D, Steward CR, Mirlekar B, Pylayeva-Gupta Y. Regulatory B cells in cancer. Immunol Rev. 2021;299:74–92.
</cite> [<a href="https://doi.org/10.1111/imr.12939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7965344/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33368346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Michaud%20D,%20Steward%20CR,%20Mirlekar%20B,%20Pylayeva-Gupta%20Y.%20Regulatory%20B%20cells%20in%20cancer.%20Immunol%20Rev.%202021;299:74%E2%80%9392." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Shepherd JH, Ballman K, Polley M-YC, Campbell JD, Fan C, Selitsky S, et al. CALGB 40603 (Alliance): Long-Term outcomes and genomic correlates of response and survival after neoadjuvant chemotherapy with or without carboplatin and bevacizumab in Triple-Negative breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2022;40:1323–34.</cite> [<a href="https://doi.org/10.1200/JCO.21.01506" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9015203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35044810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shepherd%20JH,%20Ballman%20K,%20Polley%20M-YC,%20Campbell%20JD,%20Fan%20C,%20Selitsky%20S,%20et%20al.%20CALGB%2040603%20(Alliance):%20Long-Term%20outcomes%20and%20genomic%20correlates%20of%20response%20and%20survival%20after%20neoadjuvant%20chemotherapy%20with%20or%20without%20carboplatin%20and%20bevacizumab%20in%20Triple-Negative%20breast%20cancer.%20J%20Clin%20Oncol%20Off%20J%20Am%20Soc%20Clin%20Oncol.%202022;40:1323%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Harris RJ, Willsmore Z, Laddach R, Crescioli S, Chauhan J, Cheung A, et al. Enriched Circulating and tumor-resident TGF-β + regulatory B cells in patients with melanoma promote FOXP3 + Tregs. Oncoimmunology. 2022;11:2104426.
</cite> [<a href="https://doi.org/10.1080/2162402X.2022.2104426" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9336482/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35909944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Harris%20RJ,%20Willsmore%20Z,%20Laddach%20R,%20Crescioli%20S,%20Chauhan%20J,%20Cheung%20A,%20et%20al.%20Enriched%20Circulating%20and%20tumor-resident%20TGF-%CE%B2%E2%80%89+%E2%80%89regulatory%20B%20cells%20in%20patients%20with%20melanoma%20promote%20FOXP3%E2%80%89+%E2%80%89Tregs.%20Oncoimmunology.%202022;11:2104426." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Chesneau M, Mai HL, Danger R, Le Bot S, Nguyen T-V-H, Bernard J et al. Efficient Expansion of Human Granzyme B-Expressing B Cells with Potent Regulatory Properties. J Immunol Baltim Md. 1950. 2020;205:2391–401.</cite> [<a href="https://doi.org/10.4049/jimmunol.2000335" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32948686/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Wang S, Wang J, Kumar V, Karnell JL, Naiman B, Gross PS, et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet + B cells in SLE. Nat Commun. 2018;9:1758.
</cite> [<a href="https://doi.org/10.1038/s41467-018-03750-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5931508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29717110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20S,%20Wang%20J,%20Kumar%20V,%20Karnell%20JL,%20Naiman%20B,%20Gross%20PS,%20et%20al.%20IL-21%20drives%20expansion%20and%20plasma%20cell%20differentiation%20of%20autoreactive%20CD11chiT-bet%E2%80%89+%E2%80%89B%20cells%20in%20SLE.%20Nat%20Commun.%202018;9:1758." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Austin JW, Buckner CM, Kardava L, Wang W, Zhang X, Melson VA, et al. Overexpression of T-bet in HIV infection is associated with accumulation of B cells outside germinal centers and poor affinity maturation. Sci Transl Med. 2019;11:eaax0904.
</cite> [<a href="https://doi.org/10.1126/scitranslmed.aax0904" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7479651/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31776286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Austin%20JW,%20Buckner%20CM,%20Kardava%20L,%20Wang%20W,%20Zhang%20X,%20Melson%20VA,%20et%20al.%20Overexpression%20of%20T-bet%20in%20HIV%20infection%20is%20associated%20with%20accumulation%20of%20B%20cells%20outside%20germinal%20centers%20and%20poor%20affinity%20maturation.%20Sci%20Transl%20Med.%202019;11:eaax0904." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Centuori SM, Gomes CJ, Kim SS, Putnam CW, Larsen BT, Garland LL, et al. Double-negative (CD27-IgD-) B cells are expanded in NSCLC and inversely correlate with affinity-matured B cell populations. J Transl Med. 2018;16:30.
</cite> [<a href="https://doi.org/10.1186/s12967-018-1404-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5815250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29448960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Centuori%20SM,%20Gomes%20CJ,%20Kim%20SS,%20Putnam%20CW,%20Larsen%20BT,%20Garland%20LL,%20et%20al.%20Double-negative%20(CD27-IgD-)%20B%20cells%20are%20expanded%20in%20NSCLC%20and%20inversely%20correlate%20with%20affinity-matured%20B%20cell%20populations.%20J%20Transl%20Med.%202018;16:30." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Lee M, Heo S-H, Song IH, Rajayi H, Park HS, Park IA, et al. Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis. Mod Pathol Off J U S Can Acad Pathol Inc. 2019;32:70–80.</cite> [<a href="https://doi.org/10.1038/s41379-018-0113-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30154578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20M,%20Heo%20S-H,%20Song%20IH,%20Rajayi%20H,%20Park%20HS,%20Park%20IA,%20et%20al.%20Presence%20of%20tertiary%20lymphoid%20structures%20determines%20the%20level%20of%20tumor-infiltrating%20lymphocytes%20in%20primary%20breast%20cancer%20and%20metastasis.%20Mod%20Pathol%20Off%20J%20U%20S%20Can%20Acad%20Pathol%20Inc.%202019;32:70%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Di Caro G, Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A, et al. Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin Cancer Res Off J Am Assoc Cancer Res. 2014;20:2147–58.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-13-2590" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24523438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Di%20Caro%20G,%20Bergomas%20F,%20Grizzi%20F,%20Doni%20A,%20Bianchi%20P,%20Malesci%20A,%20et%20al.%20Occurrence%20of%20tertiary%20lymphoid%20tissue%20is%20associated%20with%20T-cell%20infiltration%20and%20predicts%20better%20prognosis%20in%20early-stage%20colorectal%20cancers.%20Clin%20Cancer%20Res%20Off%20J%20Am%20Assoc%20Cancer%20Res.%202014;20:2147%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Feng H, Yang F, Qiao L, Zhou K, Wang J, Zhang J, et al. Prognostic significance of gene signature of tertiary lymphoid structures in patients with lung adenocarcinoma. Front Oncol. 2021;11:693234.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.693234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8352557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34381716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feng%20H,%20Yang%20F,%20Qiao%20L,%20Zhou%20K,%20Wang%20J,%20Zhang%20J,%20et%20al.%20Prognostic%20significance%20of%20gene%20signature%20of%20tertiary%20lymphoid%20structures%20in%20patients%20with%20lung%20adenocarcinoma.%20Front%20Oncol.%202021;11:693234." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Sautès-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19:307–25.
</cite> [<a href="https://doi.org/10.1038/s41568-019-0144-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31092904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saut%C3%A8s-Fridman%20C,%20Petitprez%20F,%20Calderaro%20J,%20Fridman%20WH.%20Tertiary%20lymphoid%20structures%20in%20the%20era%20of%20cancer%20immunotherapy.%20Nat%20Rev%20Cancer.%202019;19:307%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, et al. Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature. 2020;577:561–5.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1914-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31942071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cabrita%20R,%20Lauss%20M,%20Sanna%20A,%20Donia%20M,%20Skaarup%20Larsen%20M,%20Mitra%20S,%20et%20al.%20Tertiary%20lymphoid%20structures%20improve%20immunotherapy%20and%20survival%20in%20melanoma.%20Nature.%202020;577:561%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549–55.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1922-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8762581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31942075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Helmink%20BA,%20Reddy%20SM,%20Gao%20J,%20Zhang%20S,%20Basar%20R,%20Thakur%20R,%20et%20al.%20B%20cells%20and%20tertiary%20lymphoid%20structures%20promote%20immunotherapy%20response.%20Nature.%202020;577:549%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Petitprez F, de Reyniès A, Keung EZ, Chen TW-W, Sun C-M, Calderaro J, et al. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 2020;577:556–60.
</cite> [<a href="https://doi.org/10.1038/s41586-019-1906-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31942077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Petitprez%20F,%20de%20Reyni%C3%A8s%20A,%20Keung%20EZ,%20Chen%20TW-W,%20Sun%20C-M,%20Calderaro%20J,%20et%20al.%20B%20cells%20are%20associated%20with%20survival%20and%20immunotherapy%20response%20in%20sarcoma.%20Nature.%202020;577:556%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Ma D, Guan B, Song L, Liu Q, Fan Y, Zhao L, et al. A bibliometric analysis of exosomes in cardiovascular diseases from 2001 to 2021. Front Cardiovasc Med. 2021;8:734514.
</cite> [<a href="https://doi.org/10.3389/fcvm.2021.734514" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8424118/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34513962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20D,%20Guan%20B,%20Song%20L,%20Liu%20Q,%20Fan%20Y,%20Zhao%20L,%20et%20al.%20A%20bibliometric%20analysis%20of%20exosomes%20in%20cardiovascular%20diseases%20from%202001%20to%202021.%20Front%20Cardiovasc%20Med.%202021;8:734514." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015;105:1809–31.
</cite> [<a href="https://doi.org/10.1007/s11192-015-1645-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4643120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26594073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ellegaard%20O,%20Wallin%20JA.%20The%20bibliometric%20analysis%20of%20scholarly%20production:%20how%20great%20is%20the%20impact?%20Scientometrics.%202015;105:1809%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Ninkov A, Frank JR, Maggio LA. Bibliometrics: methods for studying academic publishing. Perspect Med Educ. 2022;11:173–6.
</cite> [<a href="https://doi.org/10.1007/s40037-021-00695-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9240160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34914027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ninkov%20A,%20Frank%20JR,%20Maggio%20LA.%20Bibliometrics:%20methods%20for%20studying%20academic%20publishing.%20Perspect%20Med%20Educ.%202022;11:173%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of pubmed, scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J Off Publ Fed Am Soc Exp Biol. 2008;22:338–42.</cite> [<a href="https://doi.org/10.1096/fj.07-9492LSF" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17884971/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Falagas%20ME,%20Pitsouni%20EI,%20Malietzis%20GA,%20Pappas%20G.%20Comparison%20of%20pubmed,%20scopus,%20web%20of%20science,%20and%20Google%20scholar:%20strengths%20and%20weaknesses.%20FASEB%20J%20Off%20Publ%20Fed%20Am%20Soc%20Exp%20Biol.%202008;22:338%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>de Winter JCF, Zadpoor AA, Dodou D. The expansion of Google scholar versus web of science: a longitudinal study. Scientometrics. 2014;98:1547–65.</cite> [<a href="https://scholar.google.com/scholar_lookup?de%20Winter%20JCF,%20Zadpoor%20AA,%20Dodou%20D.%20The%20expansion%20of%20Google%20scholar%20versus%20web%20of%20science:%20a%20longitudinal%20study.%20Scientometrics.%202014;98:1547%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Daim TU, Pilkington JRA. Innovation discovery: network analysis of research and invention activity for technology management. World Scientific; 2018.</cite>
</li>
<li id="CR32">
<span class="label">32.</span><cite>Chen C, CiteSpace II. Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57:359–77.</cite> [<a href="https://scholar.google.com/scholar_lookup?Chen%20C,%20CiteSpace%20II.%20Detecting%20and%20visualizing%20emerging%20trends%20and%20transient%20patterns%20in%20scientific%20literature.%20J%20Am%20Soc%20Inf%20Sci%20Technol.%202006;57:359%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>van Eck NJ, Waltman L. Software survey: vosviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523–38.
</cite> [<a href="https://doi.org/10.1007/s11192-009-0146-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2883932/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20585380/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Eck%20NJ,%20Waltman%20L.%20Software%20survey:%20vosviewer,%20a%20computer%20program%20for%20bibliometric%20mapping.%20Scientometrics.%202010;84:523%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Aria M, Cuccurullo C. <em>bibliometrix</em>: an R-tool for comprehensive science mapping analysis. J Informetr. 2017;11:959–75.</cite> [<a href="https://scholar.google.com/scholar_lookup?Aria%20M,%20Cuccurullo%20C.%20bibliometrix:%20an%20R-tool%20for%20comprehensive%20science%20mapping%20analysis.%20J%20Informetr.%202017;11:959%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>van Eck NJ, Waltman L. Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics. 2017;111:1053–70.
</cite> [<a href="https://doi.org/10.1007/s11192-017-2300-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5400793/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28490825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Eck%20NJ,%20Waltman%20L.%20Citation-based%20clustering%20of%20publications%20using%20CitNetExplorer%20and%20VOSviewer.%20Scientometrics.%202017;111:1053%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Synnestvedt MB, Chen C, Holmes JH. CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc AMIA Symp. 2005;2005:724–8.</cite> [<a href="/articles/PMC1560567/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16779135/" class="usa-link">PubMed</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Correa I, Plunkett T, Vlad A, Mungul A, Candelora-Kettel J, Burchell JM, et al. Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration. Immunology. 2003;108:32–41.
</cite> [<a href="https://doi.org/10.1046/j.1365-2567.2003.01562.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1782871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12519300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Correa%20I,%20Plunkett%20T,%20Vlad%20A,%20Mungul%20A,%20Candelora-Kettel%20J,%20Burchell%20JM,%20et%20al.%20Form%20and%20pattern%20of%20MUC1%20expression%20on%20T%20cells%20activated%20in%20vivo%20or%20in%20vitro%20suggests%20a%20function%20in%20T-cell%20migration.%20Immunology.%202003;108:32%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Suzuki E, Kapoor V, Jassar AS, Kaiser LR, Albelda SM. Gemcitabine selectively eliminates Splenic Gr-1+/CD11b + myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11:6713–21.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-05-0883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16166452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suzuki%20E,%20Kapoor%20V,%20Jassar%20AS,%20Kaiser%20LR,%20Albelda%20SM.%20Gemcitabine%20selectively%20eliminates%20Splenic%20Gr-1+/CD11b%E2%80%89+%E2%80%89myeloid%20suppressor%20cells%20in%20tumor-bearing%20animals%20and%20enhances%20antitumor%20immune%20activity.%20Clin%20Cancer%20Res%20Off%20J%20Am%20Assoc%20Cancer%20Res.%202005;11:6713%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>DiLillo DJ, Yanaba K, Tedder TF. B cells are required for optimal CD4 + and CD8 + T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol Baltim Md 1950. 2010;184:4006–16.</cite> [<a href="https://doi.org/10.4049/jimmunol.0903009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3733120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20194720/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?DiLillo%20DJ,%20Yanaba%20K,%20Tedder%20TF.%20B%20cells%20are%20required%20for%20optimal%20CD4%E2%80%89+%E2%80%89and%20CD8%E2%80%89+%E2%80%89T%20cell%20tumor%20immunity:%20therapeutic%20B%20cell%20depletion%20enhances%20B16%20melanoma%20growth%20in%20mice.%20J%20Immunol%20Baltim%20Md%201950.%202010;184:4006%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Ali HR, Chlon L, Pharoah PDP, Markowetz F, Caldas C. Patterns of immune infiltration in breast cancer and their clinical implications: A Gene-Expression-Based retrospective study. PLoS Med. 2016;13:e1002194.
</cite> [<a href="https://doi.org/10.1371/journal.pmed.1002194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5154505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27959923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ali%20HR,%20Chlon%20L,%20Pharoah%20PDP,%20Markowetz%20F,%20Caldas%20C.%20Patterns%20of%20immune%20infiltration%20in%20breast%20cancer%20and%20their%20clinical%20implications:%20A%20Gene-Expression-Based%20retrospective%20study.%20PLoS%20Med.%202016;13:e1002194." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Garfield E. Journal impact factor: a brief review. CMAJ Can Med Assoc J J Assoc Medicale Can. 1999;161:979–80.</cite> [<a href="/articles/PMC1230709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10551195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garfield%20E.%20Journal%20impact%20factor:%20a%20brief%20review.%20CMAJ%20Can%20Med%20Assoc%20J%20J%20Assoc%20Medicale%20Can.%201999;161:979%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Cameron F, Whiteside G, Perry C. Ipilimumab: first global approval. Drugs. 2011;71:1093–104.
</cite> [<a href="https://doi.org/10.2165/11594010-000000000-00000" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21668044/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cameron%20F,%20Whiteside%20G,%20Perry%20C.%20Ipilimumab:%20first%20global%20approval.%20Drugs.%202011;71:1093%E2%80%93104." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Deeks ED. Nivolumab: a review of its use in patients with malignant melanoma. Drugs. 2014;74:1233–9.
</cite> [<a href="https://doi.org/10.1007/s40265-014-0234-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25022950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deeks%20ED.%20Nivolumab:%20a%20review%20of%20its%20use%20in%20patients%20with%20malignant%20melanoma.%20Drugs.%202014;74:1233%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Chen X, Jensen PE. The role of B lymphocytes as antigen-presenting cells. Arch Immunol Ther Exp (Warsz). 2008;56:77–83.
</cite> [<a href="https://doi.org/10.1007/s00005-008-0014-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18373241/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20X,%20Jensen%20PE.%20The%20role%20of%20B%20lymphocytes%20as%20antigen-presenting%20cells.%20Arch%20Immunol%20Ther%20Exp%20(Warsz).%202008;56:77%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Linnemann C, van Buuren MM, Bies L, Verdegaal EME, Schotte R, Calis JJA, et al. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4 + T cells in human melanoma. Nat Med. 2015;21:81–5.
</cite> [<a href="https://doi.org/10.1038/nm.3773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25531942/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Linnemann%20C,%20van%20Buuren%20MM,%20Bies%20L,%20Verdegaal%20EME,%20Schotte%20R,%20Calis%20JJA,%20et%20al.%20High-throughput%20epitope%20discovery%20reveals%20frequent%20recognition%20of%20neo-antigens%20by%20CD4%E2%80%89+%E2%80%89T%20cells%20in%20human%20melanoma.%20Nat%20Med.%202015;21:81%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Bruno TC, Ebner PJ, Moore BL, Squalls OG, Waugh KA, Eruslanov EB, et al. Antigen-Presenting intratumoral B cells affect CD4 + TIL phenotypes in Non-Small cell lung cancer patients. Cancer Immunol Res. 2017;5:898–907.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-17-0075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5788174/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28848053/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bruno%20TC,%20Ebner%20PJ,%20Moore%20BL,%20Squalls%20OG,%20Waugh%20KA,%20Eruslanov%20EB,%20et%20al.%20Antigen-Presenting%20intratumoral%20B%20cells%20affect%20CD4%E2%80%89+%E2%80%89TIL%20phenotypes%20in%20Non-Small%20cell%20lung%20cancer%20patients.%20Cancer%20Immunol%20Res.%202017;5:898%E2%80%93907." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Rossetti RAM, Lorenzi NPC, Yokochi K, Rosa MBS, de Benevides F, Margarido L. B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses. PLoS ONE. 2018;13:e0199034.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0199034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6033398/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29975708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rossetti%20RAM,%20Lorenzi%20NPC,%20Yokochi%20K,%20Rosa%20MBS,%20de%20Benevides%20F,%20Margarido%20L.%20B%20lymphocytes%20can%20be%20activated%20to%20act%20as%20antigen%20presenting%20cells%20to%20promote%20anti-tumor%20responses.%20PLoS%20ONE.%202018;13:e0199034." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Bod L, Kye Y-C, Shi J, Torlai Triglia E, Schnell A, Fessler J, et al. B-cell-specific checkpoint molecules that regulate anti-tumour immunity. Nature. 2023;619:348–56.
</cite> [<a href="https://doi.org/10.1038/s41586-023-06231-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10795478/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37344597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bod%20L,%20Kye%20Y-C,%20Shi%20J,%20Torlai%20Triglia%20E,%20Schnell%20A,%20Fessler%20J,%20et%20al.%20B-cell-specific%20checkpoint%20molecules%20that%20regulate%20anti-tumour%20immunity.%20Nature.%202023;619:348%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Clark CM, Juan CM, Allerton BW, Otterness NS, Jun WY, Wei F. Faculty and student perceptions of academic incivility in the people’s Republic of China. J Cult Divers. 2012;19:85–93.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/23155894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clark%20CM,%20Juan%20CM,%20Allerton%20BW,%20Otterness%20NS,%20Jun%20WY,%20Wei%20F.%20Faculty%20and%20student%20perceptions%20of%20academic%20incivility%20in%20the%20people%E2%80%99s%20Republic%20of%20China.%20J%20Cult%20Divers.%202012;19:85%E2%80%9393." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Zhang W, Cheng S-Y, Hou L-F, Yan L, Tong Y-G. Genomics in personalized cancer medicine and its impact on early drug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at the 50th ASCO Annual Meeting. Chin J Cancer. 2014;33:371–5.</cite> [<a href="https://doi.org/10.5732/cjc.014.10110" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4135365/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25096543/" class="usa-link">PubMed</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Zimmerman J, Field J, Leusch F, Lowry GV, Wang P, Westerhoff P. Impact beyond impact factor. Environ Sci Technol. 2022;56:11909.
</cite> [<a href="https://doi.org/10.1021/acs.est.2c05553" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35984216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zimmerman%20J,%20Field%20J,%20Leusch%20F,%20Lowry%20GV,%20Wang%20P,%20Westerhoff%20P.%20Impact%20beyond%20impact%20factor.%20Environ%20Sci%20Technol.%202022;56:11909." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Fridman WH, Meylan M, Petitprez F, Sun C-M, Italiano A, Sautès-Fridman C. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome. Nat Rev Clin Oncol. 2022;19:441–57.
</cite> [<a href="https://doi.org/10.1038/s41571-022-00619-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35365796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fridman%20WH,%20Meylan%20M,%20Petitprez%20F,%20Sun%20C-M,%20Italiano%20A,%20Saut%C3%A8s-Fridman%20C.%20B%20cells%20and%20tertiary%20lymphoid%20structures%20as%20determinants%20of%20tumour%20immune%20contexture%20and%20clinical%20outcome.%20Nat%20Rev%20Clin%20Oncol.%202022;19:441%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science. 2022;375:eabf9419.
</cite> [<a href="https://doi.org/10.1126/science.abf9419" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34990248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schumacher%20TN,%20Thommen%20DS.%20Tertiary%20lymphoid%20structures%20in%20cancer.%20Science.%202022;375:eabf9419." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Fridman WH, Meylan M, Pupier G, Calvez A, Hernandez I, Sautès-Fridman C. Tertiary lymphoid structures and B cells: an intratumoral immunity cycle. Immunity. 2023;56:2254–69.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2023.08.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37699391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fridman%20WH,%20Meylan%20M,%20Pupier%20G,%20Calvez%20A,%20Hernandez%20I,%20Saut%C3%A8s-Fridman%20C.%20Tertiary%20lymphoid%20structures%20and%20B%20cells:%20an%20intratumoral%20immunity%20cycle.%20Immunity.%202023;56:2254%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Ruffin AT, Cillo AR, Tabib T, Liu A, Onkar S, Kunning SR, et al. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat Commun. 2021;12:3349.
</cite> [<a href="https://doi.org/10.1038/s41467-021-23355-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8184766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34099645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ruffin%20AT,%20Cillo%20AR,%20Tabib%20T,%20Liu%20A,%20Onkar%20S,%20Kunning%20SR,%20et%20al.%20B%20cell%20signatures%20and%20tertiary%20lymphoid%20structures%20contribute%20to%20outcome%20in%20head%20and%20neck%20squamous%20cell%20carcinoma.%20Nat%20Commun.%202021;12:3349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Garaud S, Zayakin P, Buisseret L, Rulle U, Silina K, de Wind A, et al. Antigen specificity and clinical significance of IgG and IgA autoantibodies produced in situ by Tumor-Infiltrating B cells in breast cancer. Front Immunol. 2018;9:2660.
</cite> [<a href="https://doi.org/10.3389/fimmu.2018.02660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6255822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30515157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Garaud%20S,%20Zayakin%20P,%20Buisseret%20L,%20Rulle%20U,%20Silina%20K,%20de%20Wind%20A,%20et%20al.%20Antigen%20specificity%20and%20clinical%20significance%20of%20IgG%20and%20IgA%20autoantibodies%20produced%20in%20situ%20by%20Tumor-Infiltrating%20B%20cells%20in%20breast%20cancer.%20Front%20Immunol.%202018;9:2660." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Montfort A, Pearce O, Maniati E, Vincent BG, Bixby L, Böhm S, et al. A strong B-cell response is part of the immune landscape in human High-Grade serous ovarian metastases. Clin Cancer Res Off J Am Assoc Cancer Res. 2017;23:250–62.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-16-0081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5928522/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27354470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Montfort%20A,%20Pearce%20O,%20Maniati%20E,%20Vincent%20BG,%20Bixby%20L,%20B%C3%B6hm%20S,%20et%20al.%20A%20strong%20B-cell%20response%20is%20part%20of%20the%20immune%20landscape%20in%20human%20High-Grade%20serous%20ovarian%20metastases.%20Clin%20Cancer%20Res%20Off%20J%20Am%20Assoc%20Cancer%20Res.%202017;23:250%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Cascone T, Leung CH, Weissferdt A, Pataer A, Carter BW, Godoy MCB, et al. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med. 2023;29:593–604.
</cite> [<a href="https://doi.org/10.1038/s41591-022-02189-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10033402/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36928818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cascone%20T,%20Leung%20CH,%20Weissferdt%20A,%20Pataer%20A,%20Carter%20BW,%20Godoy%20MCB,%20et%20al.%20Neoadjuvant%20chemotherapy%20plus%20nivolumab%20with%20or%20without%20ipilimumab%20in%20operable%20non-small%20cell%20lung%20cancer:%20the%20phase%202%20platform%20NEOSTAR%20trial.%20Nat%20Med.%202023;29:593%E2%80%93604." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Hu J, Zhang L, Xia H, Yan Y, Zhu X, Sun F, et al. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. Genome Med. 2023;15:14.
</cite> [<a href="https://doi.org/10.1186/s13073-023-01164-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9985263/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36869384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20J,%20Zhang%20L,%20Xia%20H,%20Yan%20Y,%20Zhu%20X,%20Sun%20F,%20et%20al.%20Tumor%20microenvironment%20remodeling%20after%20neoadjuvant%20immunotherapy%20in%20non-small%20cell%20lung%20cancer%20revealed%20by%20single-cell%20RNA%20sequencing.%20Genome%20Med.%202023;15:14." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Horeweg N, Workel HH, Loiero D, Church DN, Vermij L, Leon-Castillo A, et al. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients. Nat Commun. 2022;13:1373.
</cite> [<a href="https://doi.org/10.1038/s41467-022-29040-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8927106/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35296668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Horeweg%20N,%20Workel%20HH,%20Loiero%20D,%20Church%20DN,%20Vermij%20L,%20Leon-Castillo%20A,%20et%20al.%20Tertiary%20lymphoid%20structures%20critical%20for%20prognosis%20in%20endometrial%20cancer%20patients.%20Nat%20Commun.%202022;13:1373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Ding G-Y, Ma J-Q, Yun J-P, Chen X, Ling Y, Zhang S, et al. Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma. J Hepatol. 2022;76:608–18.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2021.10.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34793865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding%20G-Y,%20Ma%20J-Q,%20Yun%20J-P,%20Chen%20X,%20Ling%20Y,%20Zhang%20S,%20et%20al.%20Distribution%20and%20density%20of%20tertiary%20lymphoid%20structures%20predict%20clinical%20outcome%20in%20intrahepatic%20cholangiocarcinoma.%20J%20Hepatol.%202022;76:608%E2%80%9318." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Germain C, Gnjatic S, Dieu-Nosjean M-C. Tertiary lymphoid Structure-Associated B cells are key players in Anti-Tumor immunity. Front Immunol. 2015;6:67.
</cite> [<a href="https://doi.org/10.3389/fimmu.2015.00067" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4337382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25755654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Germain%20C,%20Gnjatic%20S,%20Dieu-Nosjean%20M-C.%20Tertiary%20lymphoid%20Structure-Associated%20B%20cells%20are%20key%20players%20in%20Anti-Tumor%20immunity.%20Front%20Immunol.%202015;6:67." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Hollern DP, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott KR, et al. B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell. 2019;179:1191–e120621.
</cite> [<a href="https://doi.org/10.1016/j.cell.2019.10.028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6911685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31730857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hollern%20DP,%20Xu%20N,%20Thennavan%20A,%20Glodowski%20C,%20Garcia-Recio%20S,%20Mott%20KR,%20et%20al.%20B%20cells%20and%20T%20follicular%20helper%20cells%20mediate%20response%20to%20checkpoint%20inhibitors%20in%20high%20mutation%20burden%20mouse%20models%20of%20breast%20cancer.%20Cell.%202019;179:1191%E2%80%93e120621." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Roumenina LT, Daugan MV, Noé R, Petitprez F, Vano YA, Sanchez-Salas R, et al. Tumor cells hijack Macrophage-Produced complement C1q to promote tumor growth. Cancer Immunol Res. 2019;7:1091–105.
</cite> [<a href="https://doi.org/10.1158/2326-6066.CIR-18-0891" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31164356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roumenina%20LT,%20Daugan%20MV,%20No%C3%A9%20R,%20Petitprez%20F,%20Vano%20YA,%20Sanchez-Salas%20R,%20et%20al.%20Tumor%20cells%20hijack%20Macrophage-Produced%20complement%20C1q%20to%20promote%20tumor%20growth.%20Cancer%20Immunol%20Res.%202019;7:1091%E2%80%93105." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Kwak JW, Laskowski J, Li HY, McSharry MV, Sippel TR, Bullock BL, et al. Complement activation via a C3a receptor pathway alters CD4 + T lymphocytes and mediates lung cancer progression. Cancer Res. 2018;78:143–56.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-17-0240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5810934/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29118090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kwak%20JW,%20Laskowski%20J,%20Li%20HY,%20McSharry%20MV,%20Sippel%20TR,%20Bullock%20BL,%20et%20al.%20Complement%20activation%20via%20a%20C3a%20receptor%20pathway%20alters%20CD4%E2%80%89+%E2%80%89T%20lymphocytes%20and%20mediates%20lung%20cancer%20progression.%20Cancer%20Res.%202018;78:143%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Selitsky SR, Mose LE, Smith CC, Chai S, Hoadley KA, Dittmer DP, et al. Prognostic value of B cells in cutaneous melanoma. Genome Med. 2019;11:36.
</cite> [<a href="https://doi.org/10.1186/s13073-019-0647-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6540526/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31138334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Selitsky%20SR,%20Mose%20LE,%20Smith%20CC,%20Chai%20S,%20Hoadley%20KA,%20Dittmer%20DP,%20et%20al.%20Prognostic%20value%20of%20B%20cells%20in%20cutaneous%20melanoma.%20Genome%20Med.%202019;11:36." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Zirakzadeh AA, Sherif A, Rosenblatt R, Ahlén Bergman E, Winerdal M, Yang D, et al. Tumour-associated B cells in urothelial urinary bladder cancer. Scand J Immunol. 2020;91:e12830.
</cite> [<a href="https://doi.org/10.1111/sji.12830" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31823416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zirakzadeh%20AA,%20Sherif%20A,%20Rosenblatt%20R,%20Ahl%C3%A9n%20Bergman%20E,%20Winerdal%20M,%20Yang%20D,%20et%20al.%20Tumour-associated%20B%20cells%20in%20urothelial%20urinary%20bladder%20cancer.%20Scand%20J%20Immunol.%202020;91:e12830." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, et al. Increased regulatory B cells are involved in immune evasion in patients with gastric cancer. Sci Rep. 2019;9:13083.
</cite> [<a href="https://doi.org/10.1038/s41598-019-49581-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6739478/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31511630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Murakami%20Y,%20Saito%20H,%20Shimizu%20S,%20Kono%20Y,%20Shishido%20Y,%20Miyatani%20K,%20et%20al.%20Increased%20regulatory%20B%20cells%20are%20involved%20in%20immune%20evasion%20in%20patients%20with%20gastric%20cancer.%20Sci%20Rep.%202019;9:13083." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Ishigami E, Sakakibara M, Sakakibara J, Masuda T, Fujimoto H, Hayama S, et al. Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer. Breast Cancer Tokyo Jpn. 2019;26:180–9.</cite> [<a href="https://doi.org/10.1007/s12282-018-0910-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30244409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ishigami%20E,%20Sakakibara%20M,%20Sakakibara%20J,%20Masuda%20T,%20Fujimoto%20H,%20Hayama%20S,%20et%20al.%20Coexistence%20of%20regulatory%20B%20cells%20and%20regulatory%20T%20cells%20in%20tumor-infiltrating%20lymphocyte%20aggregates%20is%20a%20prognostic%20factor%20in%20patients%20with%20breast%20cancer.%20Breast%20Cancer%20Tokyo%20Jpn.%202019;26:180%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117:530–41.
</cite> [<a href="https://doi.org/10.1182/blood-2010-07-294249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3031478/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20962324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Iwata%20Y,%20Matsushita%20T,%20Horikawa%20M,%20Dilillo%20DJ,%20Yanaba%20K,%20Venturi%20GM,%20et%20al.%20Characterization%20of%20a%20rare%20IL-10-competent%20B-cell%20subset%20in%20humans%20that%20parallels%20mouse%20regulatory%20B10%20cells.%20Blood.%202011;117:530%E2%80%9341." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Matsumoto M, Baba A, Yokota T, Nishikawa H, Ohkawa Y, Kayama H, et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity. 2014;41:1040–51.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2014.10.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25484301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matsumoto%20M,%20Baba%20A,%20Yokota%20T,%20Nishikawa%20H,%20Ohkawa%20Y,%20Kayama%20H,%20et%20al.%20Interleukin-10-producing%20plasmablasts%20exert%20regulatory%20function%20in%20autoimmune%20inflammation.%20Immunity.%202014;41:1040%E2%80%9351." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32:129–40.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2009.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20079667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Blair%20PA,%20Nore%C3%B1a%20LY,%20Flores-Borja%20F,%20Rawlings%20DJ,%20Isenberg%20DA,%20Ehrenstein%20MR,%20et%20al.%20CD19(+)CD24(hi)CD38(hi)%20B%20cells%20exhibit%20regulatory%20capacity%20in%20healthy%20individuals%20but%20are%20functionally%20impaired%20in%20systemic%20lupus%20erythematosus%20patients.%20Immunity.%202010;32:129%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Parekh VV, Prasad DVR, Banerjee PP, Joshi BN, Kumar A, Mishra GC. B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8 + T cells: role of TGF-beta 1. J Immunol Baltim Md 1950. 2003;170:5897–911.</cite> [<a href="https://doi.org/10.4049/jimmunol.170.12.5897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12794116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Parekh%20VV,%20Prasad%20DVR,%20Banerjee%20PP,%20Joshi%20BN,%20Kumar%20A,%20Mishra%20GC.%20B%20cells%20activated%20by%20lipopolysaccharide,%20but%20not%20by%20anti-Ig%20and%20anti-CD40%20antibody,%20induce%20anergy%20in%20CD8%E2%80%89+%E2%80%89T%20cells:%20role%20of%20TGF-beta%201.%20J%20Immunol%20Baltim%20Md%201950.%202003;170:5897%E2%80%93911." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Ng KW, Boumelha J, Enfield KSS, Almagro J, Cha H, Pich O, et al. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature. 2023;616:563–73.
</cite> [<a href="https://doi.org/10.1038/s41586-023-05771-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10115647/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37046094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ng%20KW,%20Boumelha%20J,%20Enfield%20KSS,%20Almagro%20J,%20Cha%20H,%20Pich%20O,%20et%20al.%20Antibodies%20against%20endogenous%20retroviruses%20promote%20lung%20cancer%20immunotherapy.%20Nature.%202023;616:563%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Wang Q, Sun K, Liu R, Song Y, Lv Y, Bi P, et al. Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy. Clin Transl Med. 2023;13:e1346.
</cite> [<a href="https://doi.org/10.1002/ctm2.1346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10390819/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37525587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Q,%20Sun%20K,%20Liu%20R,%20Song%20Y,%20Lv%20Y,%20Bi%20P,%20et%20al.%20Single-cell%20transcriptome%20sequencing%20of%20B-cell%20heterogeneity%20and%20tertiary%20lymphoid%20structure%20predicts%20breast%20cancer%20prognosis%20and%20neoadjuvant%20therapy%20efficacy.%20Clin%20Transl%20Med.%202023;13:e1346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Gibellini L, De Biasi S, Porta C, Lo Tartaro D, Depenni R, Pellacani G, et al. Single-cell approaches to profile the response to immune checkpoint inhibitors. Front Immunol. 2020;11:490.
</cite> [<a href="https://doi.org/10.3389/fimmu.2020.00490" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7100547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32265933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gibellini%20L,%20De%20Biasi%20S,%20Porta%20C,%20Lo%20Tartaro%20D,%20Depenni%20R,%20Pellacani%20G,%20et%20al.%20Single-cell%20approaches%20to%20profile%20the%20response%20to%20immune%20checkpoint%20inhibitors.%20Front%20Immunol.%202020;11:490." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>Schina A, Sztupinszki Z, Marie Svane I, Szallasi Z, Jönsson G, Donia M. Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy. J Immunother Cancer. 2023;11:e006941.
</cite> [<a href="https://doi.org/10.1136/jitc-2023-006941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10445359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37604641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schina%20A,%20Sztupinszki%20Z,%20Marie%20Svane%20I,%20Szallasi%20Z,%20J%C3%B6nsson%20G,%20Donia%20M.%20Intratumoral%20T-cell%20and%20B-cell%20receptor%20architecture%20associates%20with%20distinct%20immune%20tumor%20microenvironment%20features%20and%20clinical%20outcomes%20of%20anti-PD-1/L1%20immunotherapy.%20J%20Immunother%20Cancer.%202023;11:e006941." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Vito A, Salem O, El-Sayes N, MacFawn IP, Portillo AL, Milne K, et al. Immune checkpoint Blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells. Commun Biol. 2021;4:859.
</cite> [<a href="https://doi.org/10.1038/s42003-021-02375-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8275624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34253827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vito%20A,%20Salem%20O,%20El-Sayes%20N,%20MacFawn%20IP,%20Portillo%20AL,%20Milne%20K,%20et%20al.%20Immune%20checkpoint%20Blockade%20in%20triple%20negative%20breast%20cancer%20influenced%20by%20B%20cells%20through%20myeloid-derived%20suppressor%20cells.%20Commun%20Biol.%202021;4:859." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Das R, Bar N, Ferreira M, Newman AM, Zhang L, Bailur JK, et al. Early B cell changes predict autoimmunity following combination immune checkpoint Blockade. J Clin Invest. 2018;128:715–20.
</cite> [<a href="https://doi.org/10.1172/JCI96798" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5785243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29309048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Das%20R,%20Bar%20N,%20Ferreira%20M,%20Newman%20AM,%20Zhang%20L,%20Bailur%20JK,%20et%20al.%20Early%20B%20cell%20changes%20predict%20autoimmunity%20following%20combination%20immune%20checkpoint%20Blockade.%20J%20Clin%20Invest.%202018;128:715%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Nishimura K, Konishi T, Ochi T, Watanabe R, Noda T, Fukumoto T, et al. CD21lo B cells could be a potential predictor of Immune-Related adverse events in renal cell carcinoma. J Pers Med. 2022;12:888.
</cite> [<a href="https://doi.org/10.3390/jpm12060888" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9225635/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35743673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nishimura%20K,%20Konishi%20T,%20Ochi%20T,%20Watanabe%20R,%20Noda%20T,%20Fukumoto%20T,%20et%20al.%20CD21lo%20B%20cells%20could%20be%20a%20potential%20predictor%20of%20Immune-Related%20adverse%20events%20in%20renal%20cell%20carcinoma.%20J%20Pers%20Med.%202022;12:888." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Gonugunta AS, von Itzstein MS, Mu-Mosley H, Fattah F, Farrar JD, Mobely A, et al. Humoral and cellular correlates of a novel immune-related adverse event and its treatment. J Immunother Cancer. 2021;9:e003585.
</cite> [<a href="https://doi.org/10.1136/jitc-2021-003585" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8655605/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34880115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gonugunta%20AS,%20von%20Itzstein%20MS,%20Mu-Mosley%20H,%20Fattah%20F,%20Farrar%20JD,%20Mobely%20A,%20et%20al.%20Humoral%20and%20cellular%20correlates%20of%20a%20novel%20immune-related%20adverse%20event%20and%20its%20treatment.%20J%20Immunother%20Cancer.%202021;9:e003585." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Sterner RC, Sterner RM. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 2021;11:69.
</cite> [<a href="https://doi.org/10.1038/s41408-021-00459-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8024391/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33824268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sterner%20RC,%20Sterner%20RM.%20CAR-T%20cell%20therapy:%20current%20limitations%20and%20potential%20strategies.%20Blood%20Cancer%20J.%202021;11:69." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Wang Z, Wu Z, Liu Y, Han W. New development in CAR-T cell therapy. J Hematol OncolJ Hematol Oncol. 2017;10:53.
</cite> [<a href="https://doi.org/10.1186/s13045-017-0423-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5320663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28222796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Z,%20Wu%20Z,%20Liu%20Y,%20Han%20W.%20New%20development%20in%20CAR-T%20cell%20therapy.%20J%20Hematol%20OncolJ%20Hematol%20Oncol.%202017;10:53." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Maalej KM, Merhi M, Inchakalody VP, Mestiri S, Alam M, Maccalli C, et al. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer. 2023;22:20.
</cite> [<a href="https://doi.org/10.1186/s12943-023-01723-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9885707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36717905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maalej%20KM,%20Merhi%20M,%20Inchakalody%20VP,%20Mestiri%20S,%20Alam%20M,%20Maccalli%20C,%20et%20al.%20CAR-cell%20therapy%20in%20the%20era%20of%20solid%20tumor%20treatment:%20current%20challenges%20and%20emerging%20therapeutic%20advances.%20Mol%20Cancer.%202023;22:20." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–7.
</cite> [<a href="https://doi.org/10.1038/nmeth.3337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4739640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25822800/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Newman%20AM,%20Liu%20CL,%20Green%20MR,%20Gentles%20AJ,%20Feng%20W,%20Xu%20Y,%20et%20al.%20Robust%20enumeration%20of%20cell%20subsets%20from%20tissue%20expression%20profiles.%20Nat%20Methods.%202015;12:453%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.
</cite> [<a href="https://doi.org/10.1186/s13059-017-1349-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5688663/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29141660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aran%20D,%20Hu%20Z,%20Butte%20AJ.%20xCell:%20digitally%20portraying%20the%20tissue%20cellular%20heterogeneity%20landscape.%20Genome%20Biol.%202017;18:220." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Zhang L, Zheng H, Jiang S-T, Liu Y-G, Zhang T, Zhang J-W et al. Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis. Int J Surg [Internet]. 2024;110. Available from: <a href="https://journals.lww.com/international-journal-of-surgery/fulltext/2024/03000/worldwide_research_trends_on_tumor_burden_and.41.aspx" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://journals.lww.com/international-journal-of-surgery/fulltext/2024/03000/worldwide_research_trends_on_tumor_burden_and.41.aspx</a>.</cite> [<a href="https://doi.org/10.1097/JS9.0000000000001022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10942200/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38181123/" class="usa-link">PubMed</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Liu B, He X, Wang Y, Huang J, Zheng Y, Li Y et al. Bibliometric Analysis of γδ T Cells as Immune Regulators in Cancer Prognosis. Front Immunol [Internet]. 2022. Available from: <a href="https://www.frontiersin.org/journals/immunology/articles/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/journals/immunology/articles/</a>; 10.3389/fimmu.2022.874640.</cite> [<a href="https://doi.org/10.3389/fimmu.2022.874640" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9048597/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35493488/" class="usa-link">PubMed</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Wu Z, Zhang Y, Gong Y, Hu J. Knowledge landscape of Treg research in breast cancer: a bibliometric and visual analysis. Front Oncol. 2024;14:1448714.
</cite> [<a href="https://doi.org/10.3389/fonc.2024.1448714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11631855/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39664195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20Z,%20Zhang%20Y,%20Gong%20Y,%20Hu%20J.%20Knowledge%20landscape%20of%20Treg%20research%20in%20breast%20cancer:%20a%20bibliometric%20and%20visual%20analysis.%20Front%20Oncol.%202024;14:1448714." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Jiang D, Wen P, Zhang S, Zhang N, Shao Q, Wang G et al. Knowledge mapping of tumor microenvironment for breast cancer: a bibliometric analysis from 2014 to 2023. Front Immunol [Internet]. 2025. Available from: <a href="https://www.frontiersin.org/journals/immunology/articles/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/journals/immunology/articles/</a>; 10.3389/fimmu.2025.1550988.</cite> [<a href="https://doi.org/10.3389/fimmu.2025.1550988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11983549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40213549/" class="usa-link">PubMed</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Huang Z, Xie T, Xie W, Chen Z, Wen Z, Yang L. Research trends in lung cancer and the tumor microenvironment: a bibliometric analysis of studies published from 2014 to 2023. Front Oncol [Internet]. 2024. Available from: <a href="https://www.frontiersin.org/journals/oncology/articles/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.frontiersin.org/journals/oncology/articles/</a>; 10.3389/fonc.2024.1428018.</cite> [<a href="https://doi.org/10.3389/fonc.2024.1428018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11322073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39144829/" class="usa-link">PubMed</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12373629/bin/12672_2025_3458_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Additional file 1.</a><sup> (4.4MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data supporting the findings of this study are available within the paper. For more information, please contact the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Discover Oncology are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s12672-025-03458-3"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12672_2025_Article_3458.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.8 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12373629/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12373629/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12373629%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12373629/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12373629/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12373629/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40846795/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12373629/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40846795/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12373629/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12373629/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="Zd3GtO5E0H56HsGI8oUpVQUe8j8Le2D5Eu09FYXpadTFdQUWasm2lNUFXPZIgi6v">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
